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Abstract 
 
 
 
In this dissertation, we study a new model of medical device infection – that of a fibrin infected 
with the common blood borne pathogen Staphylococcus epidermidis, which is shown to 
influence fibrin mechanically and structurally on both microscopic and macroscopic scales. S. 
epidermidis present during clot formation produces a visibly disorganized microstructure that 
increases clot stiffness and triggers mechanical instability over time.  
 
We also noticed that the capacity for S. epidermidis to modulate fibrin formation kinetics, 
mechanics and microstructure is a function of bacterial growth phase. We continued to find that 
the bacteria-fibrinogen interaction is also growth phase dependent: stationary-phase (biofilm-like) 
S. epidermidis has an increased and stronger adhesion to fibrinogen as compared to exponential-
phase (planktonic) ones. Furthermore, the gene expression for SdrG – the protein that adheres S. 
epidermidis cells to fibrinogen was significantly increased in the stationary phase.  
 
We extended our understanding on the effect of S. epidermidis on fibrin by investigating a 
specific protein – IcaB, a cell surface-attached protein that has a key role in staphylococcal 
biofilm formation and immune evasion. It deacetylates and introduces positive charge to 
polysaccharide intercellular adhesin (PIA) molecules; these charges facilitate adhesion of 
bacterial cells within a biofilm cluster. Using an icaB deletion strain, we evaluated the effects of 
 
xii 
PIA deacetylation on staphylococcal interaction with a fibrin network and the resulting structural 
and mechanical changes to the network. We find that the ∆𝑖𝑐𝑎𝐵 strain degrades fibrin networks 
to a higher degree than the wild-type, both structurally and mechanically. Structurally, the 
connected branches in a fibrin network infected with the ∆𝑖𝑐𝑎𝐵  strain become disconnected 
patches. Mechanically, a fibrin network infected with the ∆𝑖𝑐𝑎𝐵 strain becomes more liquid-like 
and deformative. Indeed, the ∆𝑖𝑐𝑎𝐵  produce more sspA, a protease that putatively degrades 
fibrin. We further demonstrate that the ∆𝑖𝑐𝑎𝐵 cells, which are more diffusive than the wild type 
cells, co-localize with the fibrin fibers. This co-localization is correlated with fibrin network 
degradation.  
 
 
In our study of infected fibrin, we noticed some limitations in the mechanical characterization 
using rheometers, e.g. the challenge of delivering additives in situ. This inspired us to develop a 
rheometer tooling comprised of a porous hydrogel. The tooling allows additives to be dosed 
through a rheometer plate or cone, and the consequent effect of these additives on a material’s 
mechanical response measured. We demonstrated that the tooling can be used to study the 
kinetics of material property variation due to the diffusion of molecular additives into the soft 
material though the hydrogel plate.  
 
Overall, our understanding of fibrin infected with S. epidermidis aids in understanding of 
medical device infections and infection-induced thromboembolism.  
  
 
1 
1 Chapter 1: Introduction 
 
While lives have been improved by indwelling medical devices such as heart valves, 
endovascular stents, joint prostheses, ventricular assist devices, artificial hearts, etc., they are 
causing problems at the same time. Indwelling medical devices contribute to 50 to 70% of the 
nearly two million healthcare-associated infections1, 2, ranking as the fifth leading cause of death 
in US acute-care hospitals3. Causes for indwelling medical device infections include surgical 
sterility and abiotic device materials 4 5 6. While the former has been improving and shown some 
infection rate decreases 4, research on the latter has failed in many clinical experiments 7 and 
therefore has not been widely embraced 8. 
 
A surgical wound generated by device implantation allows exposure of the abiotic material to 
extracellular fluids, bacteria and blood. This then leads to bacterial adhesion and the activation of 
host immune and coagulation systems 9. Besides the bio-incompatibility of the device materials, 
bacteria also activate inflammation, triggering the formation of blood clots which, in turn, 
promote bacterial adhesion 9. This bidirectional relationship also contributes to the co-existence 
of bacteria and host, with the host being mostly blood clots and bacteria stay as biofilms – 
surface-attached cellular communities encapsulated in matrix materials 10. Motivated by medical 
device infections, isolated biofilms have been widely researched with an increasing attention11. 
However, little is know about the co-existence of biofilms and blood clots –the interactions 
between them and the properties of the complex. Thus, a study of the biofilm-host complex 
would contribute to the current understanding of indwelling medical device infection.  
 
2 
1.1 Blood Clots and Fibrin 
Clots, the result of blood coagulation, are critical to the control of bleeding and the healing of the 
wound. A clot forms when platelets are activated and the coagulation cascade is triggered by the 
exposure of collagen and tissue factors to blood 12.  Clots form through fibrinogen (Fg) 
polymerization into fibrin (Fn) as catalyzed by thrombin 13 14. During this process, blood cells 
and platelets are trapped by fibrin (Fn) fibers in the fibrin network. Fibrin is the fundamental 
structural component of a clot 15 16 17; it is a primary determinant of clot mechanical properties, 
stability and strength 18 19 20. Artificial fibrin system has been therefore widely studied to discuss 
its rheological and microstructural properties 15 16. 
 
Clot mechanics can be qualitatively characterized by many methods including rheometers 15 16, 
light scattering 21, ultrasound 22, etc. For small deformations, a fibrin clot behaves as a nearly 
perfect elastic gel on the macroscopic scale 16. One the microscopic scale, microrheology has 
been applied to study fibrin mechanics 23 24 25. The premise of microrheology is that the motion 
of a probe particle reflects its local mechanical environment 23 26 27. Techniques include 
microscopic multiple-particle tracking (MPT), light scattering, magnetic tweezers, etc.28. Such 
research suggests that the macroscopic elasticity of fibrin arise from single fibrin fibers 23, 
especially their bending motion 25.  
 
The structure of the fibrin network, including its porosity, fiber thickness, and branch point 
density, determine clot mechanics. Mesh size – the average distance between fibers – is a widely 
used structural parameter that plays an important role in fibrin mechanics 16. Confocal scanning 
laser microscopy (CLSM) is a great tool to study fibrin network structure and characterize fibrin 
mesh size 16 23. CLSM can be used to study the structure at the same time apply microrheology 
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by MPT with the help of image processing techniques based on the Crocker and Grier algorithm 
29. In addition, electron microscopes can provide clear images of dried fibrin, showing fiber 
length, diameter, branch point density, etc. 15.  
 
1.2 Staphylococcus epidermidis biofilms 
S.epidermidis is a gram-positive, non-motile bacterial strain that dominates the human skin flora 
30 31. It is coagulase-negative; that is, it does not produce coagulase, an enzyme that enables the 
conversion of fibrinogen to fibrin in blood or plasma by reacting with prothrombin. The selection 
of a coagulase negative pathogen is parsimonious as it removes the potential confounder of 
bacterial enzyme-mediated clot formation and focuses solely on the co-localization of bacteria 
and thrombus.  In addition, despite the ubiquitous presence of coagulase negative species such as 
S. epidermidis in bloodstream and medical device infections, prior studies of the interaction 
between bacteria and fibrin has been more focused on coagulase-positive strains (e.g., 
Staphylococcus aureus) 32 33.  
 
Though harmless to the skin, S.epidermidis can be dangerous when it gets into the bloodstream 
for its primary virulence of forming a biofilm 34. A biofilm is a bacterial community that occurs 
when bacteria attach to a surface, alter their phenotype and produce a protective layer of 
extracellular polymeric substance (EPS). A significant cause of clinical infections, biofilms 
present a significant obstacle to treatment with traditional antimicrobials and physical shear 30. 
The life cycle of a biofilm begins when bacteria adhere to a surface followed by colonization 
where bacteria multiply rapidly with exponential growth and produce EPS. The densely 
populated biofilm bacteria slow their growth to a stationary phase. Finally, some bacteria must 
detach as planktonic bacteria to attach and start a new biofilm colony elsewhere. Each life cycle 
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stage requires different proteins and mechanisms to be most effective and the bacteria display 
phenotypic changes as they progress from planktonic to biofilm stages 9 35. While the change in 
phenotype is key in biofilm formation, little attention is paid to the differences in the 
exponential versus stationary growth phase of biofilm formers 35 36 37.  
 
The EPS is crucial to the survival of a biofilm: 1) it’s important for biofilm formation: the 
adhesive property of EPS polymers facilitates the tight packing of the biofilm bacteria 38 39 40 41 
42; 2) it determines the mechanical properties of a biofilm: the polysaccharides in the matrix 
mediates the reversible and irreversible deformation of a mature biofilm and it resists the 
premature fragmentation under shear stress 43 44 45; 3) it protects the biofilm from antibiotics by 
largely reducing the diffusion rate of antibiotics in biofilms 46 47 48 and trapping and/or 
deactivating the antibiotics through interactions46, 49. In S. epidermidis, the EPS contains 
polysaccharide intercellular adhesin (PIA) 50, 51, matrix binding proteins52, accumulation 
associated proteins, extracellular proteins and nucleic acids53, 54. PIA is attracting a great amount 
of interests for its crucial role in biofilm formation55, mechanics56 and persistence in vivo55.  
 
1.3 Bacterial interaction with fibrin 
A fibrin network covering a biofilm can be both advantageous and disadvantageous to a biofilm. 
It reinforces the structure and strength of a biofilm33 32 while limiting its growth and preventing 
it from infecting other places 57. Coagulase-positive bacteria generate and incorporate fibrin 
network into their biofilm structure to protect them from the immune evasion and antibiotics 58 
32. On the other hand, clots generated by the immune system can inhibit pathogen dissemination 
and survival 57.  
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Bacterial infection is a significant risk factor for thrombosis and thromboembolism 59, 60 61.  An 
important virulence factor of many bacterial strains is their ability to develop biofilms, 
especially on implanted medical devices. Clinically, thrombosis and bacterial biofilms often 
present simultaneously, especially on implanted medical devices62,63. Indeed, Lordick et al. 
found that 12 of 14 patients with central venous catheter (CVC) related infection had a 
preceding CVC related venous thrombosis64. Also, in patients with recent infection compared 
with patients without infection, cardioembolic stroke was more frequent (34% versus 
19%; P<0.05)61.  
 
1.4 Bacterial gene expression and surface properties 
Cell surface properties play an important role in bacterial interaction with fibrin. First of all, 
under physiological conditions, S.epidermidis bacterial cells are negatively charged whereas the 
clotting agents – fibrinogen, fibrin and thrombin are all positively charged. This coulomb 
interaction may have an impact on the structure, mechanics and instability of the fibrin network23. 
 
Second, there are receptors on bacterial cell surfaces. For example, S.epidermidis has a gene 
called sdrG (also known as fbe) that encodes the production of the well described surface protein 
SdrG (also known as Fbe which binds fibrinogen in a “lock, dock and latch” mechanism 65 66. As 
another example, a gene called sspA is involved in the production of glutamyl endopeptidase and 
serine protease that putatively degrades fibrin 67 30. Moreover, there could also be other genes 
that indirectly influence the bacterial interaction with fibrin. For instance, a surface protein IcaB 
deacetylates and introduces positive charges in the PIA polymer chain and controls whether PIA 
stays on cell walls 55. It therefore influences cell surface properties, which may play an important 
role in cell-fibrin interaction.  
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1.5 Rheological Measurement during the delivery of a second agent 
In the study of the mechanics of fibrin infected by staphylococcal biofilms, rheometry is one of 
the key techniques for its important role in characterizing the macroscopic mechanical 
properties of soft matter materials, such as fibrin and biofilms. However, current rheological 
methods have limited capabilities to study the transient rheology that results from the dosing 
with molecular additives. Currently, to conduct such measurements, all components must be 
mixed together ex situ.  The mixture is then loaded onto the rheometer. In some cases, this 
process is inadequate.  Potential problems include: difficulty in establishing an initial time point 
for the additive dosing; uncontrolled deformation during the loading of the material – to which 
the additive performs its function – onto the rheometer; difficulties in mimicking physiological 
or industrial conditions, etc. For example, to study the mechanics of fibrin formation, fibrinogen 
and thrombin may need to be loaded onto a cold rheometer plate and the temperature is then 
increased to body temperature after the preparation23. In this case, the temperature effect is 
ignored in the study. The development of a rheology tooling that could measure mechanics 
while delivering an addictive to the sample can aid such study: the fibrinogen solution can be 
loaded first before thrombin is diffused into it. This would better mimic the physiological 
scenarios.  
 
The feasibility of developing a rheometer tooling that allows diffusion during measurements 
would not only benefit the above example, but a lot more of both scientific and technological 
research. In biological systems, for example, there is interest in studying the transient rheology 
of blood clot fibrinolysis as plasmin diffuses into and dissolves clots 68 and the interactions 
between blood clots and continuously growing bacterial biofilms69. There is also interest in 
studying the transient rheology of colloidal suspensions during gelation 70. Industrial examples 
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where transient measurements are important include the addition of thickeners, gelling agents, 
and emulsifiers to food products 71, the use of reactive polymeric materials as rheology modifiers 
of lubricating greases in the oil industry 72, and the control over ionic strength in micelle 
solutions to change the flow properties in consumer products 73.  
 
1.6 Research goals and organization of the dissertation 
The overarching goal of this dissertation is to investigate the bacterial interaction with a fibrin 
network and determine the impact of bacteria on fibrin mechanics, structure and instability. The 
studies include two limits of a spectrum of possibilities:  In one limit, the role of bacterial cell 
growth is minimized by direct introduction of the physiologically relevant concentration of 
bacterial cells and then study of the effect of these cells on fibrin network formation.  In the 
second limit, the role of fibrin network formation kinetics is minimized by pre-assembly of a 
fibrin network in which bacterial cells are then introduced and allowed to proliferate. 
Experimental models are built to mimic these two scenarios as shown in Figure 1-1. The 
molecular mechanisms are also explored to aid in the understanding of the characterized 
phenomena. Overall, this study will contribute to the current understanding of medical device 
contaminations and motivate relevant future in vivo and clinical studies.  
	
Figure 1-1 | Sketches of experimental models of the two limits of a spectrum of possibilities. 
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A sketch of (a) fibrin formation at fixed bacterial concentration and (b) pre-assembled fibrin 
network with proliferating bacterial biofilms inside a confocal microscope coverslip well. Red 
lines indicate fibrin oligomers, blue circles indicate bacteria, orange rectangle indicates a volume 
of bacteria culturing medium. 
 
In Chapter 2, we built an in vitro new model for medical device infection – that of a fibrin clot 
infected with the common blood borne pathogen Staphylococcus epidermidis. To do this, we 
directly introduced the physiologically relevant concentration of bacterial cells to a forming 
fibrin clot with the role of bacterial growth minimized as indicated in Figure 1-1(a). We 
characterized the infected fibrin’s formation kinetics, mechanics, structure and instability on 
both the macroscopic and microscopic scale. We applied rheology and photography to study the 
behaviors on the macroscopic scale and confocal laser scanning microscopy (CLSM), image 
analysis, particle tracking and microrheology to study the microscopic phenomena. 
 
In Chapter 3, we explained potential mechanisms that leads to the phenomena noticed in 
Chapter 2 on a molecular level. We hypothesized that stationary-phase (biofilm-like) S. 
epidermidis will have a more robust effect on clot kinetics and elasticity than exponential-phase 
(planktonic) ones. Rheology and confocal microscopy is used to evaluate the difference in the 
mechanics and structure, respectively, of the fibrin network infected by the exponential and 
stationary phase S. epidermidis. We then evaluated the capacity for S. epidermidis to bind to 
fibrinogen as a function of its growth phase. We first tested the relevant gene expressions, 
especially for SdrG – the protein that adheres S.epidermidis cells. A functional in vitro model 
was developed to evaluate adhesion of S. epidermidis to a fibrinogen coated surface in a 
continuously flowing environment. The bacterial deposition rate onto fibrinogen and the 
residence time are characterized. Flow cytometry is also applied to determine the amount of 
 
9 
fibrinogen molecules attracted to cell walls. We correlated the growth-dependent SdrG 
expressions and fibrinogen-binding capacities to the growth-dependent effects on fibrin network 
to offer a potential explanation of the noticed phenomena in Chapter 2. 
 
In Chapter 4, we pre-assembly of a fibrin network in which bacterial cells are then introduced 
and allowed to proliferate to study the scenario where a very small amount of bacteria grow 
inside an established fibrin network with the effect of the kinetics of the fibrin formation 
minimized as indicated in Figure 1-1 (b). With this model, we investigated the effect of IcaB, or, 
the role of the deacetylation and the introduction of positive charges to PIA molecules, on the 
bacterial interaction with fibrin. We first characterized structural and mechanical changes of the 
infected fibrin networks during the bacterial proliferation using confocal microscopy and 
microrheology. We then correlated the characterized phenomena with cell location relative to 
fibrin, cell mobility, cell surface charges and sspA expression by applying image processing, 
particle tracking zeta potential measurements, RNA extraction and reverse transcription 
polymerase chain reaction (RT-PCR), respectively. 
 
In Chapter 5, we developed rheometer tooling comprised of a porous hydrogel that allows us to 
dose solvents and other additives to materials as their mechanical response is measured. We 
synthesized a disposable hydrogel rheometer plate through photopolymerization of an aqueous 
polyethylene glycol (PEG) diacrylate solution. We controlled the precision of the tooling by 
fixing the mold to a five-axis optomechanical stage. We demonstrated the performance of the 
tooling by measuring viscoelastic properties of aqueous polyethylene oxide (PEO) solutions and 
comparing the values to those obtained using standard fixtures. We further offered examples of 
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self-assembled and gel soft matter that demonstrate that the tooling can be used to study the 
kinetics of material property variation due to the diffusion of molecular additives though the 
hydrogel plate.  
 
Finally, we discuss the overall conclusions and future work that could be investigated as a result 
of the body of work included in this dissertation.  
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2 Chapter 2: Structure, mechanics, and instability of fibrin clot infected 
with Staphylococcus epidermidis1 
 
2.1 Abstract 
Health care associated infection, over half of which can be attributed to indwelling medical 
devices, is a strong risk factor for thromboembolism. Although most experimental models of 
medical device infection draw upon isolated bacterial biofilms, in fact there is no infection 
without host protein contribution. Here we study a new model for medical device infection – that 
of an infected fibrin clot – and show that the common blood borne pathogen Staphylococcus 
epidermidis influences this in vitro model of a blood clot mechanically and structurally on both 
microscopic and macroscopic scales. Bacteria present during clot formation produce a visibly 
disorganized microstructure that increases clot stiffness and triggers mechanical instability over 
time. Our results provide insight into the observed correlation between medical device infection 
and thromboembolism; the increase in model clot heterogeneity shows that S. epidermidis can 
rupture a fibrin clot.  The resultant embolization of the infected clot can contribute to the 
systemic dissemination of the pathogen.  
																																																						
1	The work of Chapter 2 is published as “Structure, mechanics, and instability of fibrin clot infected 
with Staphylococcus epidermidis” by Tianhui Ma, J. Scott VanEpps, and Michael Solomon. Biophysical 
Journal (2017)	
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2.2 Introduction:  
Clotting, the result of blood coagulation, is critical to hemostasis (i.e., the control of bleeding). 
Clots normally appear at a site of injury to prevent bleeding, restore barrier function, and 
promote wound healing. However, abnormal clot conditions (i.e., thrombosis) can lead to disease. 
For example, if a thrombus embolizes, it can circulate and block downstream arteries in the lung 
(pulmonary embolism) or brain (stroke)1,2.  
 
Bacterial infection is a significant risk factor for thromboembolism3,4 5.  An important virulence 
factor of many bacterial strains is their ability to develop biofilms, especially on implanted 
medical devices.  Biofilms are bacterial communities embedded in a protective extracellular 
polymeric substance comprised of polysaccharide, proteins, and DNA6.  Clinically, thrombosis 
and bacterial biofilms often present simultaneously, especially on implanted medical devices7,8. 
Indeed, Lordick et al. found that 12 of 14 patients with central venous catheter (CVC) related 
infection had a preceding CVC related venous thrombosis9.   
 
Most experimental models of bacterial biofilm infection on implanted medical devices utilize 
isolated, single-species bacterial biofilms generated on a variety of biomaterials10 11.  However, 
bacterial contamination of medical devices involves the co-localization of bacteria as biofilms 
and host proteins as clot.  For example, implanted abiotic materials provide a niche for 
attachment and development of bacterial biofilms while also activating host inflammatory and 
coagulation cascades which lead to fibrin clots12.  In this paper, we develop an experimental 
model of medical device infection that combines biofilm-forming bacteria and host clot.  The in 
vitro model of clot in this report is a fibrin network, as polymerized by thrombin.  Fibrin is the 
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fundamental structural component of a clot13,14,15; it is the primary determinant of clot 
mechanical properties, stability, and strength16.  
 
To research infected clots, two limits of a spectrum of possibilities are available for study design.  
In one limit, the role of bacterial cell growth is minimized by direct introduction of the 
physiologically relevant concentration of bacterial cells and then study of the effect of these cells 
on fibrin network formation.  In the second limit, the role of fibrin network formation kinetics is 
minimized by pre-assembly of a fibrin network in which bacterial cells are then introduced and 
allowed to proliferate. Realistically, infected clots fall within these two limits. In the present 
work, we have selected the former study design, because it produces direct information about 
bacterial-fibrin interactions, albeit with the understanding that both limits are of research interest.    
 
We therefore introduce Staphylococcus epidermidis cells during the thrombin-induced 
polymerization of fibrinogen to mimic host clot forming on device surfaces in the presence of 
this pathogen. S.epidermidis is an innocuous commensal microorganism on human skin but can 
be pathogenic once introduced to the bloodstream or colonized on implanted devices17. 
Specifically, it is the leading cause of indwelling medical device contaminations/infection18 and 
is commonly associated with infective thrombosis19. It is coagulase-negative; that is, it does not 
produce coagulase, an enzyme that enables the conversion of fibrinogen to fibrin in blood or 
plasma by reacting with prothrombin. The selection of a coagulase negative pathogen is 
parsimonious as it removes the potential confounder of bacterial enzyme-mediated clot 
formation and focuses solely on the co-localization of bacteria and thrombus.  In addition, 
despite the ubiquitous presence of coagulase negative species such as S. epidermidis in 
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bloodstream and medical device infections, prior studies of the interaction between bacteria and 
fibrin has been more focused on coagulase-positive strains (e.g., Staphylococcus aureus)20,21. 
The bacterial concentrations applied in this study are similar to the biofilm cell density found in a 
rabbit model of central venous catheter infection22. 
 
In this work the structure, mechanics, and instability of the infected clot is compared to cell-free 
clot. The structure of the fibrin network is characterized by its fiber thickness and mesh size, the 
latter being the average distance between neighboring strands of fibers. These structural 
properties determine clot mechanical properties that are critical to both normal function and 
pathology15. Clinically, clot elasticity – that is, clot stiffness – is measured to diagnose 
hemostatic defects, such as abnormalities in clot formation/dissolution kinetics and clot 
strength23,. Moreover, clot instability – that is, propensity for rupture and embolization – and the 
effectiveness of medical treatments are a function of clot mechanics.  The viscoelastic properties 
of a thrombus determine whether blood flow causes deformation, rupture, or embolization of the 
clot24,15,25.  
 
In this study we first use rheometry to show the mechanical influence of S. epidermidis on fibrin 
clot formation and its elasticity. Second, using confocal microscopy, we evaluate changes in the 
microstructure of fibrin clots after the addition of S. epidermidis cells. Third, we connect the 
changes in infected clot elasticity to the changes in fibrin network structure using multiple 
particle tracking (MPT) microrheology. Fourth, through microscopic image analysis, we describe 
the time variation of fibrin filament area, bacteria-fibrin overlap, and network mesh size in an 
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infected fibrin clot. Finally, by combining microscopy and time-lapse photography, we show 
mesoscopic and macroscopic instability of the infected clot structure at long times.  
 
2.3 Materials and Methods 
2.3.1 Bacterial strain and culture conditions. 
S.epidermidis RP62A, a biofilm-forming strain was obtained from American Type Culture 
Collection (ATCC 35984). One colony from a Lysogeny broth (LB) plate was inoculated in a 
flask (125 ml) containing 32 ml tryptic soy broth with 1 wt. % glucose (TSBG) and cultured at 37 ℃ at 200 rpm of continuous shaking for approximately nine hours to an optical density at 600nm 
(OD600) = 1.35±0.1. 
 
2.3.2 Fibrin Clot and Infected Fibrin Clot Constitution.  
Citrate-free thrombin from human plasma (605206-100U) and fibrinogen (Fg) from human 
plasma (341576-100MG) were purchased from EMD Millipore Corporation (Billerica, MA, 
USA). Fibrinogen solutions were made by diluting the stock solution with Hank's Balanced Salt 
Solution (HBSS) (1X) (with Calcium, Magnesium, no phenol red, 1g/L D-Glucose, Thermo 
Fisher Scientific, Waltham, MA, USA) at 37℃.  
 
After reaching the prescribed OD600, the bacterial suspension was allowed to stand quiescently at 
room temperature for one hour so large cell clusters could sediment. A INCYTO™ C-Chip™ 
Disposable Hemacytometer (Thermo Fisher Scientific, Waltham, MA, USA) was used to 
determine the cell concentration.  A target number of cells were re-suspended in the Fg solution 
so as to achieve the desired final cell concentration. The introduced cell concentrations for bulk 
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rheology measurements were 1×109cells/ml, 2×109cells/ml, 4×109cells/ml and 6×109cells/ml. 
These values are similar to the 105 CFU/cm2 cell density found in a rabbit model of central 
venous catheter infection22. A cell concentration of 4×109cells/ml was used for the remaining 
experiments. Specifically, a volume of the bacterial culture was centrifuged (15000g, 40s) and 
washed twice with HBSS; the resulting bacterial pellet was suspended in Fg solution. The Fg 
solution or the cell-Fg mixture was kept on ice for 3 minutes before clot initiation by adding 
thrombin (0.5U/ml as final concentration). Then the samples were loaded to either the rheometer 
(5℃) or to a NuncTM Lab-TekTM II Chambered Coverglass dish (Thermo Scientific, USA) (kept 
on ice). The rheometer temperature was increased to 37℃ after loading and the chambered 
coverglass was held in a 37℃ incubator. The chamber coverglass was sealed with parafilm to 
prevent desiccation. The effect of cold fibrin initiation is discussed in Figure 2-1. 
 
 
Figure 2-1 | Influence of initial temperature and probes on fibrin structures  
Mesh size characterization of pure fibrin and infected fibrin clot under different conditions. Error 
bars denote standard deviations of all the stacks in n = 3. The “37dC” protocol is the following: 
The fibrinogen (Fg) solution, the cell-Fg mixture and the chamber coverglass dishes were kept in 
a 37℃ dry bath incubator for temperature to reach 37℃. Solutions were loaded to the chamber 
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coverglass dishes and 0.5U/ml thrombin (final concentration) was added to initiate the 
polymerization. Chamber coverglass dishes were kept in a 37℃ incubator afterwards.  
 
2.3.3 Clot Elasticity 
Clot elasticity was characterized by measuring the linear elastic modulus, 𝐺/, on a mechanical 
rheometer (TA Instruments AR-G2, cone and plate fixture with a 2° cone angle and a 40 mm 
diameter). All tests were performed at a frequency 𝜔 =	0.1 Hz under an imposed strain 𝛾 = 0.01 
at 37℃ in a humid atmosphere. Clot desiccation was further prevented by coating the sample 
edge with a thin layer of mineral oil14. Loading the sample in the rheometer at 5°C delayed 
clotting until the instrument was prepared for measurement. After loading, the rheometer reached 
37℃ in about one minute; measurements were initiated 30 s later. Experiments were stopped 
after steady-state was reached, defined as the variability in 𝐺/ in any 2 min interval being no 
more than 0.5% for 20 minutes. The steady-state elastic modulus was taken as the average of all 
the data within the steady-state region with error bars denoting standard deviation of all 
replicates. 
 
2.3.4 Microstructure visualization and multiple particle tracking. 
Image volumes (3D) and time series (2D) of fibrin and bacterial cell microstructure were 
acquired using a Nikon A1Rsi confocal laser scanning microscope with a 100x, 1.45 NA, oil 
immersion objective. Specimens were prepared in a NuncTM Lab-TekTM II Chambered 
Coverglass dish. Image volumes for microstructure visualization and analysis were obtained by 
axially scanning from the coverslip to 50 µm above the coverslip in increments of 1 µm. The 
image size was 127.45×127.45 µm2 (at either 512×512 pixel or  1019×1019 pixel resolution). For 
multiple-particle tracking, two-dimensional time series of 900 images with size 42.48×42.48µm2 
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(512×512pixels) were collected at 15 frames per second at a distance of 20±5µm above 
coverslip. Both z-stacks and time series were captured randomly with in the specimen dish. 
Images projections of corresponding height and renderings of 3D volumes were made in ImageJ 
(http://rsbweb.nih. gov/ij/).  
 
Stains used were Alexa Fluor 647 (650/668nm) or Alexa Fluor 546 (~558/573 nm) conjugate 
human Fg (Thermo Fisher Scientific, Waltham, MA, USA), which was mixed with unlabeled 
fibrinogen in a molar ratio of 1:4 in HBSS. The non-fluorescent Fg concentration was kept 
constant in all experiments and the extra dyed fibrinogen did not affect pure fibrin clot 
mechanical properties (see Figure 2-2). Bacterial cells were stained for 30 minutes with 20µM 
SYTO® 40 (420/441) (Thermo Fisher Scientific, Waltham, MA, USA) and washed twice with 
HBSS before re-suspension in Fg solutions.  
 
	
Figure 2-2 | Influence of fluorescent Fg on fibrin formation and mechanical properties 
Elastic modulus G’ variance over time of fibrin with and without fluorescent Fg. Error bars 
denote standard error of the mean of n = 3. 
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Carboxylate-Modified Polystyrene Microspheres, 1.0 µm, red fluorescent (FluoSpheres® 
580/605), 2% solids and Sulfate Microspheres, 1.0 µm, yellow-green fluorescent (FluoSpheres® 
505/515), 2% solids (Thermo Fisher Scientific Waltham, MA, USA) were used for particle 
tracking microrheology..  
 
Bovine Serum Albumin (BSA, Sigma-Aldrich St. Louis, MO, USA) was adsorbed to the 
microsphere surface to control the microsphere’s propensity for adsorption to fibrin.  BSA was 
dissolved in filtered deionizing (DI) water. The two different probes (0.1% solids as the final 
concentration) were incubated with 1 wt.% and 15 wt.% BSA solutions, respectively, on a roller 
at room temperature for 24 hours. Different probes were washed separately with DI water and re-
suspended into Fg or bacterial/Fg solution before clotting with the following concentration: 0.04% 
solids for 1wt% BSA incubated probes and 0.02% solids for 15wt% BSA incubated ones. In pure 
fibrin, the former adsorbed to fibers, while the latter diffused freely in the voids of the network. 
In the infected clot, however, initially free probes become bound to fibrin after about 30 minutes.  
 
2.3.5 Network structure quantification 
Fiber Area, bacteria-fibrin overlap percentage and mesh size – the average distance between 
neighboring strands of fibers – were calculated from binary images, derived from a threshold 
equal to the image mean intensity of every image, as described by Bendix et al 26. After 
thresholding, fibers and bacteria cells are on-pixels and voids are off-pixels in their respective 
channels. The fiber area was computed by counting the number of fiber on-pixels. Fiber area was 
normalized by the largest value in the reported time range. Bacteria-fibrin overlap pixels are on-
pixels in both the bacteria and fiber channels (c.f Figure 2-3). The overlap percentage of every 
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image was computed by dividing the overlap area by the fiber area. Image analysis was done in 
Matlab R2014b (The MathWorks, Natick, MA). 
 
	
Figure 2-3 | Fiber area and bacteria-fibrin overlap percentage 
 (a) Single image of the fibrin channel, (b) bacteria channel, and (c) the merged threshold images 
for the infected clot, in which fibrin is red, bacteria are blue and the overlap regions are magenta. 
Scale bar = 10 µm. 
 
To compute the mesh size, distances between on-pixels for the fibrin channel were recorded by 
scanning along pixel rows and columns. Along each dimension, distributions of distances were 
least-squares fitted to a Poisson distribution, 𝑃 = 	𝑃6𝑒89 9:, with 𝑃6 and the decay length 𝜉6 -- 
taken as the mesh size -- as the fitting parameters.  Example analyses for pure fibrin and infected 
fibrin clots are in Figure 2-4, respectively. The dependence of mesh size fitting on threshold 
values is negligible around the mean intensity as reported in Figure 2-4c. The mesh size of each 
image was obtained by averaging the fitted mesh size for all rows and columns. Two populations 
were resolved for infected clots because the distribution of distances between fibers could not be 
described by a single Poisson distribution (c.f. Methods and Figure 2-4b). Steady-state mesh size 
values were calculated by averaging all the stacks in all replicates (at the time interval 60 – 100 
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min). The reported values for mesh size, fiber area and overlap percentage are the average of all 
stacks from 20µm to 40µm above the coverslip, acquired at 1µm intervals within the reported 
time point ± 10min. No less than four sets of z-stacks were included in each reported time bin. 
The error bars denote the standard deviation of all the stacks in all replicates.   
 
 
	
Figure 2-4 | Mesh Size Characterization 
Distribution of distances between fibers measured in rows (blue ’*’) and columns (orange ‘o’) 
and single mode and bimodal exponential fits for (a) pure fibrin and (b) infected fibrin clot, 
respectively. The insets are the corresponding confocal 2D slice (left) and its threshold image 
(right). Scale bar = 10 µm. (c) Threshold-dependence of mesh size results. The threshold value 
used in this study is the mean intensity of the according slice: the grey line denotes 26% -- the 
mean intensity of (a) and that of (b) was 23% as denoted by the red line.  
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2.3.6 Microrheology 
	
Particle tracking has been used in a variety of research topics27,28,29. In this study, microrheology 
measurements were performed by multiple-particle tracking (MPT) with confocal microscopy. 
The premise of MPT microrheology is that the motion of a probe particle reflects its local 
mechanical environment28,29. Fluorescent polystyrene spheres of 1𝜇𝑚 as described above were 
used as probes. There were two kinds of probes -- free ones that undergo Brownian motion in 
fibrin voids and bound ones that attach to and fluctuate with the fibrin fibers. From the 
trajectories we quantified the probes’ mean square displacement (MSD) ( ∆𝑥@ 𝑡 ) -- the average 
squared distance a probe travels in a given lag time -- as reported in Figure 2-5 a,b. MSDs were 
computed from probes’ centroids as identified by Trackpy 3.0 (http://soft-
matter.github.io/trackpy/stable/). The static error of the MSD was determined to be ∆𝑥@ 𝑡 BCD = 2×108H𝜇𝑚@ by tracking fully immobilized probes at the coverslip30. The MSD 
of the pure fibrin and infected fibrin clots are 83 and 23 times higher than the static error, 
respectively. In a purely viscous environment the MSD increases linearly with lag time, like the 
free probes in the voids that contain only buffer (Figure 2-5b). For an elastic material, the MSD 
exhibits a plateau, independent of lag time, like the behavior of the probes bound to fibrin 
(Figure 2-5a).  Probes bound to the pure fibrin and the infected fibrin clots exhibit plateau MSD 
magnitudes that differ. That is, the probes are localized in space to differing degrees; probes in 
the infected clot display a lower plateau MSD (Figure 2-5a) than probes in pure fibrin.  By MPT 
microrheology, these MSD magnitudes are inversely proportional to the elastic modulus: 
                                                         𝐺/ = IJKLM(∆OP Q )S→U                           (equation 1) 
Where, 𝑘W is the Boltzmann constant, 𝑇 is the temperature, 𝑎 is the probe radius and (∆𝑥@ 𝑡 ) is 
the MSD31,32.  This expression was used to calculate the MPT elastic moduli reported in the 
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Results. Three time series movies were obtained for each replicate. The MSD ( ∆𝑥@ 𝑡 ) of each 
replicate was obtained by averaging the tracked particles in the three movies. (∆𝑥@ 𝑡 )Q→Y was 
calculated by averaging ∆𝑥@ 𝑡  values within lag time equal to 10 seconds. The G’ value of 
this replicate is then calculated from equation (1).  
 
	
Figure 2-5 | Multiple Particle Tracking Microrheology (MPT) of pure fibrin and infected 
fibrin clot 
 (a) Mean square displacement (MSD) curves of probes trapped (15wt% BSA-treated) onto fibrin 
fibers at steady state. (b) Mean square displacement (MSD) curves of probes freely undergoing 
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Brownian motion (1wt% BSA-treated) in solvent voids in HBSS buffer, voids of a pure fibrin, 
and voids of an infected clot (10 minute after clotting and 20±5µm above coverslip). Error bars 
denote standard deviation of n=3. 
 
2.3.7 Macroscopic clot rupture visualization 
Pure fibrin clots and infected fibrin clots were constituted as described above and in an 8-well 
chamber coverglass and kept in a 37℃ incubator. Samples were taken out of the incubator and 
photographed every 40±10min.  
 
2.3.8 Comparison of cold vs. warm clot initiation  
Warm clot initiation was conducted as following: The fibrinogen (Fg) solution, the cell-Fg 
mixture and the chamber coverglass dishes were kept in a 37℃  dry bath incubator (Fisher 
Scientific™ Isotemp™ Digital and Analog Dry Bath Incubators) for temperature to reach 37℃. 
Solutions were loaded to the chamber coverglass dishes and 0.5U/ml thrombin (final 
concentration) was added to initiate the polymerization. Chamber coverglass dishes were kept in 
a 37℃ incubator afterwards.  
 
Cold clot initiation was conducted as described in Methods in the main text. It is used in order to 
1) allow time to load the samples on the rheometer plate, 2) capture the entire clotting process. 
We did not observe significant differences in the trends for mesh size observed for cold clot 
initiation compared to 37℃ clot initiation (c.f. Figure 2-1).  Likewise, macroscopic photos of 
infected fibrin clots with 37℃ clot initiation demonstrated similar trends in heterogeneity (64%; 
14 out of 22 cases) within ten hours as cold initiated clots.  
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2.3.9 Fluorescent Fibrin Clot Constitution for Bulk Rheology Measurements 
Alexa Fluor 546 (~558/573 nm) conjugate human Fg (Thermo Fisher Scientific, Waltham, MA, 
USA) was mixed with unlabeled fibrinogen in a molar ratio of 1:4 in HBSS. The non-fluorescent 
Fg concentration was kept constant (0.5mg/ml) in all experiments. 
 
2.3.10 Plasminogen-depleted Fibrin Clot Constitution  
Plasminogen-depleted fibrinogen (341578) was purchased from EMD Millipore Corporation 
(Billerica, MA, USA); in all protocols it was used equivalently to the primary plasminogen 
source. 
 
2.3.11 Scanning Electron Microscopy  
Clots were prepared for scanning electron microscopy (SEM) from mixtures of S.epidermidis 
cells (4×109cells/ml), 0.5mg/ml fibrinogen and 0.5U/ml thrombin (final concentration) in HBSS 
buffer, the same way as described in Methods. Mixtures were prepared on ice. A drop of ~50𝜇𝑙 
was quickly transferred on to a glass slide pre-coated with 5 wt.% bovine serum albumin (BSA) 
in PBS buffer overnight. The glass slides were kept in 37℃ for at least 30min before making the 
samples. After 70min, samples were fixed with 2.5% glutaraldehyde overnight at 4℃. Clots were 
then washed three times in distilled water, dehydrated in a graded series of increasing ethanol 
concentrations (30–100%) over three hours. The specimens were mounted, sputter-coated with 
gold on the SPI-Module Sputter Coater at 2.2kV and 20mA for 40 seconds. Samples was 
examined in the FEI Nova NanoLab SEM, under 5kV and 0.40nA, and digitalized micrographs 
were taken under magnifications ranging between 10000-80000X. 
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2.3.12 Image Analysis for large pore volume fraction 
Large pore volume fraction is estimated from its area fraction in the same binary images used for 
network structure quantifications (c.f. Methods).  
𝜙\M]^_	`a]_b = 	#	𝑜𝑓	(𝑓𝑖𝑏𝑒𝑟	𝑝𝑖𝑥𝑒𝑙𝑠 + 	𝑠𝑚𝑎𝑙𝑙	𝑝𝑜𝑟𝑒𝑠	𝑝𝑖𝑥𝑒𝑙𝑠)#	𝑜𝑓	𝑡𝑜𝑡𝑎𝑙	𝑝𝑖𝑥𝑒𝑙𝑠  
in which the fiber pixels and the small pore pixels are the black ones and the blue ones, 
respectively, in Figure 2-6. The blue small pores are determined as the enclosed region 
containing no more than the average pore size in a pure fibrin. This calculation should 
underestimate the large pore volume fraction due to confocal microscope axial limitations – 
every slide is actually a 1𝜇𝑚 projection. The blurry fibers should be fibers out of the plane. 
However, they are counted as fibers in the binary images with the used threshold method 
therefore lead to multiple times of counting.  
	
Figure 2-6 Large pore volume fraction 
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A single stack of infected fibrin channel (left) and its binary image (right). Black pixels denote 
fibrin fibers, blue pixels denote small pores, white pixels denote large pores that are elastically 
inactive.  
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2.4 Results: 
2.4.1 S. epidermidis alters the elasticity of fibrin clots. 
	
Figure 2-7 | S. epidermidis alters fibrin elasticity. 
Elastic modulus, G’, of pure fibrin clot (0.5mg/ml) and infected fibrin clots (0.5mg/ml fibrin 
with 1×109cells/ml, 2×109cells/ml, 4×109cells/ml, 6×109cells/ml) variation with time. Error bars 
denote standard deviation with n=3.  
 
Figure 2-7 reports the effect of bacterial cells on fibrin clot elasticity, as quantified by the linear 
elastic modulus G′.  Without cells, the elasticity of a 0.5 mg/ml pure fibrin clot emerges rapidly, 
attaining a steady-state value of 1.5 ± 0.2 Pa in ~40 min.  The addition of 1×109cells/ml has 
modest effect on the elastic response.  However, at higher cell concentrations, the kinetics of the 
elastic response becomes more complex.  Initially the process is retarded and the modulus has a 
transient plateau at a value less than the steady-state modulus of the pure fibrin clot. Then the 
elastic modulus rapidly increases to a final steady-state value greater than that of the pure fibrin 
clot. The dynamics are cell concentration dependent. Specifically, an infected fibrin clot with the 
highest cell concentration (6×109 cells/ml) reaches its steady-state G/	value in about half the time 
of an infected fibrin clot with 2×109 cells/ml. However, as shown in Figure 2-8, the steady-state 
elastic modulus is about 1.4 times greater at the lower concentration (2×109 cells/ml) than the 
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higher concentration (6×109cells/ml).  For cell concentrations between 2×109 cells/ml and 
6×109cells/ml, the final steady-state modulus is about 3-4.2 times greater than the pure fibrin 
clot.  
 
Cell conc. [cells/ml] 0 2×109 4×109 6×109 
Steady state G’ [Pa] 1.5±0.2 6.3±0.9 5.7±1.0 4.5±0.5 
 
	
Figure 2-8  | Steady state G’ values of infected fibrin clots depend on bacterial cell 
concentration 
Table and graph both show the steady state (c.f. Methods) linear elastic modulus, G’, values for 
infected clots with different S. epidermidis cell concentrations. Error bars denote standard 
deviation of n=3. 
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2.4.2 S. epidermidis generates a heterogeneous fibrin clot microstructure.  
	
Figure 2-9 | Steady-state microstructure of fibrin clot and infected fibrin clot 
(a) Axial projections of a pure fibrin clot (0.5mg/ml) and (b) an infected clot (with 4×109cells/ml 
in 0.5mg/ml fibrin) showing the existence of large pores. Fibrin is red and bacterial cells are blue.  
(c) High-resolution image from identified region of interest in (a). (d) High-resolution image 
from region of interest in (b).  Scale bar = 10 µm in (a-d). (e) Mesh size characterization of 
steady state pure fibrin clot and infected fibrin clot. Error bars denote standard deviations of all 
the image stacks in all five replicates (c.f. Methods).  
 
Figure 2-9 compares the steady-state microstructure (c.f. Methods) of a fibrin clot with that of an 
infected clot with 4×109 S. epidermidis cells/ml added.  The pure fibrin network is homogeneous 
and porous with distinct filaments and voids.  Image analysis indicates that the mesh size (c.f. 
Methods) is 5.9 ± 1.1	µm (Figure 2-9a, c, and e), consistent with previous measurements in the 
literature13. The network formed by the infected clot, on the other hand, is heterogeneous (Figure 
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2-9b and d).  Inspection of the image projections suggests that the network mesh size structure 
cannot be described by a single length scale. Indeed, image analysis detects two characteristic 
mesh size dimensions (c.f. Methods). The two sizes detected (2.6 ± 1.0	µm and 23.1 ± 9.8	µm) 
differ by about a factor of ten (Figure 2-9e). The larger pore size in the infected clot network is 
about four times the pore size in the pure fibrin clot.  Figure 2-9d shows details of the small 
pores, which are about half the size of the homogeneous pure fibrin network in Figure 2-9c.  
 
2.4.3 Microrheology connects microstructure and elasticity.  
	
Figure 2-10 Multiple Particle Tracking (MPT) Microrheology in fibrin and infected clots 
(a) One image stack from a time series images of MPT in a pure fibrin and infected clot. Fibrin is 
red; bacteria are blue; Probes bound to fibrin are yellow; freely diffusing probes are green (c.f. 
Methods). The zoomed-in plots show the trajectories of the bound probes in pure fibrin and 
infected fibrin, respectively. The fluctuation of probes bound to fibrin is inversely proportional to 
the elastic modulus. (b) Comparison between steady state elastic modulus G’ obtained from bulk 
rheology and G’ calculated from MPT (c.f. Methods).  Error bars denote standard deviations 
with n = 3.   
 
We hypothesized that the observed changes in clot elasticity (Figure 2-7) could be attributed to 
the heterogeneous structure generated by the presence of S.epidermidis (Figure 2-9). To test this 
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hypothesis, we measured, by microrheology33, the change in elastic modulus 𝐺′ of the fibrin 
network, as induced by added bacteria. The elastic modulus was characterized by direct 
visualization of the microscopic dynamics of the fibrin network. The mean-squared displacement 
(MSD) of submicron particle probes embedded in an elastic medium was used to characterize the 
medium’s elastic modulus 𝐺′ (c.f. Methods).  Physically, the more localized the fluctuating 
displacements of the probe, the greater the elastic modulus of the medium. We found significant 
differences in probe MSD in pure fibrin and infected fibrin clots (Figure 2-10a).  These 
differences yield elastic moduli that differ by a factor of 3.6±1.2 (Figure 2-10b), consistent with 
the bulk rheology in Figure 2-7.  Thus, differences in the dynamics of the fibrin network with 
and without cells correlate with the different elastic moduli of pure fibrin and infected fibrin 
clots.  
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2.4.4 S. epidermidis changes the microstructure of a fibrin clot over time 
	
Figure 2-11 | Infected fibrin clot formation and rupture 
 (a) Axial projections of an infected clot (4×109cells/ml in 0.5mg/ml fibrin) rendered from 20 
m m to 30 m m above the cover slip at 1 m m intervals at different time points. Fibrin is stained red 
and bacteria are stained blue. Scale bar = 10 µm in all images. (b,c) Renderings of three-
dimensional image volume of (b) a pure fibrin clot and (c) the region in the infected clot showed 
in (a), captured 150 minutes after adding thrombin. The width and height of volumes in (b) and 
(c) are 127 µm and 50 µm, respectively. 
 
Confocal microscopy images in Figure 2-11a demonstrate how the structure of an infected fibrin 
clot evolves over time. Fibrin becomes visible as red pixels on the confocal microscope once 
fibrinogen monomers are polymerized into fibrin fibers by thrombin. Blue stained cells in the 
zoomed-in images show the transition from free floating cells that are evenly distributed at 
30min to cells adhered onto the fibrin fibers between 60min and 150min. The change in fibrin 
color from red to pink is due to the co-localization of the fibrin (red) and the bacteria (blue). The 
large pores of the infected fibrin clot increase in size over time. The three-dimensional confocal 
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microscopy volumes of a pure fibrin clot (Figure 2-11b) and the corresponding region in the 
infected fibrin clot at 150 min (Figure 2-11c) shows that the latter has a greater heterogeneity in 
terms of fibrin structure and distribution of bacteria. Again, in this case the fibrin is co-localized 
with bacteria or bacterial aggregates. 
 
	
Figure 2-12 | Microstructural change during the infected fibrin clotting process 
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The variance of (a) normalized fiber area, (b) bacteria fibrin overlap percentage and (c) mesh 
sizes during the infected fibrin and the pure fibrin clotting process. Error bars denote standard 
deviation of n=5. 
 
The temporal variation of normalized fibrin area, bacteria-fibrin overlap percentage (bacteria-
fibrin overlap area / fibrin area), and mesh size are reported in Figure 2-12 (c.f. Methods). The 
fiber area of the infected clots increases until around 50 min and then remains constant (Figure 2-
12a). The fiber area measurement characterizes the formation of the fibrin network as fibrinogen 
monomers are consumed to form visible fibrin.  Compared to the pure fibrin curve, the formation 
of an infected clot is considerably slowed.  This result agrees with the macroscopic elastic 
response reported in Figure 2-7.   
 
Figure 2-12b shows the bacteria-fibrin overlap percentage. There is little overlap before 10 min – 
bacterial cells are free floating within this interval.  The percentage increases until 70 min at 
which time it reaches a plateau of nearly 80%. That is, nearly 80% of the fibrin is covered with 
cells.  The critical point of this cell-binding event (~30 min) is on the same time scale as the 
second step in Figure 2-7 (4×10s𝑐𝑒𝑙𝑙𝑠/𝑚𝑙).  That is, the transition from the first plateau to the 
second plateau of G’ coincides with cell-fibrin association.   
 
The mesh size variation with time of pure and infected clot is reported in Figure 2-12c. The pure 
fibrin mesh size is nearly independent of time.  For the infected clots, the small pore size is also 
steady.  However, the average size of the large pores first decreases in size (before 50 min) and 
then reaches a minimum at ~ 70 min. After 90 min, however, both large pore mean value and its 
standard deviation increase again. This increase in both standard deviation and the difference 
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between the small and large pore size indicates an increase in spatial heterogeneity in the 
network, consistent with the images in Figure 2-11. 
 
2.4.5 S. epidermidis effects on fibrin microstructure and elasticity lead to 
macroscopic changes in infected clots at long times 
 
	
Figure 2-13 | Multiscale imaging of infected fibrin clots 
Confocal microscopy three-dimensional volumes of (a) a pure fibrin clot and (b) an infected clot, 
imaged 5 h. Fibrin is stained red; cells are stained blue.  The width and height of the volumes are 
254 µm and 10 µm, respectively. (c) Triplicate time-lapse photos of infected fibrin clots with 
 
42 
4×109cells/ml (top three rows) compared to pure fibrin clot (bottom row) in chamber coverglass 
wells. Scale bar in the first photo = 3mm.  
 
To test the effect of S.epidermidis on fibrin clots at longer times, we first used confocal 
microscopy to capture the mesoscopic heterogeneity of the network five hours after adding 
thrombin (Figure 2-13a,b). It shows that the heterogeneity of the infected clot persisted and 
increased in dimension to the mesoscopic scale; in comparison the pure fibrin clot remains 
homogeneous. We further found that S. epidermidis can change a fibrin clot macroscopically; 
time-lapse images of infected fibrin clots and a pure fibrin clot in chamber glass wells are 
reported in Figure 2-13c.  Pure fibrin clot is homogeneous and transparent. The infected clot is 
turbid due to the presence of the S. epidermidis cells.  This macroscopic opacity – both its 
intensity and its spatial distribution – is a function of the cell distribution in the infected clot.  
This cell distribution tracks the distribution of fibrin because cells adhere to the fibrin network 
(Figure 2-11 & 2-12).  The images of the infected fibrin clots initially show spatially 
homogeneous turbidity.  However, beginning at about 180 min, visual evidence of local 
imperfections becomes apparent.  These local imperfections grow in size. At late times, the 
previously contiguous fibrin clot now appears torn or ruptured; the central region is clear and 
free of turbidity. Within ten hours, macroscopic heterogeneity was observed in 74% (17 out of 
23) of the infected fibrin clots studied.  No heterogeneity was observed in any of the ten pure 
fibrin clot controls, consistent with microscopic observations of homogeneous, time-independent 
fibrin microstructure for up to ten hours (c.f. Figure 2-14) as well as optical density 
measurements of the fibrin network itself (c.f. Figure 2-15).   
 
 
43 
	
Figure 2-14 | Pure fibrin maintains its microstructure for at least 10h 
25 uniformly-spaced positions were imaged across the sample at each given time point. Two Z-
stacks of pure fibrin microstructures reported here are representative of the 25 images at the 
corresponding given time points. The microstructure is not significantly changed after 10 hrs, 
suggesting that any fibrinolytic proteins in the fibrinogen media are not active in the cell-free 
controls.  Scale bar = 10 µm. 
 
	
Figure 2-15 | Pure Fibrin Optical Density Over Spectrum and Time 
Pure fibrin optical density was measured with a Biotek Spectrophotometer B20. (a) Within the 
range of the visible light spectrum, the optical density of a pure fibrin specimen at one hour after 
clot initiation is lower than 0.1, and therefore difficult to visualize with the naked eye. (b) The 
optical density of the pure fibrin specimen is low and constant with time at three different 
wavelengths (700nm, 550nm, 400nm). This experiment, taken together with the microstructural 
information, confirms that no structural changes occur in the pure fibrin networks over time. 
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The observations of infected clot instability are maintained when physiological concentrations of 
albumin are added to the HBSS buffer (c.f. Figure 2-16).  Moreover, when the fibrin network is 
constituted from plasminogen-depleted fibrinogen solution, clot heterogeneity is still observed; 
however, the kinetics of instability is different, as quantified by the reduced probability of 
macroscopic rupture (1 of 11 for plasminogen-depleted specimens vs 17 of 23 for the primary 
plasminogen source), at 10 hours, c.f. Figure 2-17).  Therefore, quantitative details of the 
infected clot heterogeneous structure and instability depend on whether or not the fibrinogen 
solution is depleted of plasminogen.  Because some strains of Staphylococcus can produce 
enzymes that degrade host proteins (e.g. by converting plasminogen to plasmin) 17 , this 
observation offers a potential mechanistic explanation for the rupture and remodeling of fibrin by 
S.epidermidis.   
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Figure 2-16 Infected Clot constituted with Bovine Serum Albumin (BSA) added to HBSS 
solution 
 (a) Axial projections of an infected fibrin formed in a solvent containing 7mg/ml BSA 
(physiological albumin to fibrinogen ratio). Fibrin is red, S. epidermidis is blue. (Compare to 
Figure 2-9b) (c) Triplicate infected fibrin clots formed in BSA-HBSS solvent in chamber 
coverglass wells at 10h (Compare to Figure 2-13c). This result shows that bacterial-fibrin 
interactions remain the same in a system that contains the most abundant plasma protein, present 
at physiological levels.  
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Figure 2-17 | Infected Clot with Plasminogen-depleted Fibrinogen 
 (a) Axial projections of an infected fibrin clot formed with plasminogen-depleted fibrinogen 
(Compare to Figure 2-9b). (b) Confocal microscopy three-dimensional volumes of an infected 
clot formed with plasminogen-depleted fibrinogen, imaged 5 h. Fibrin is stained red; cells are 
stained blue.  The width and height of the volumes are 254 µm and 10 µm, respectively. Fibrin is 
red, S.epidermidis is blue (Compare to Figure 2-13b). (c) Three replicates of infected fibrin clots 
formed with plasminogen-depleted fibrinogen in chamber coverglass wells at 10h (one out of 11 
samples showed noticeable heterogeneity) and 24h (five out of 11 samples showed noticeable 
heterogeneity). Arrows show the regions of rupture. The inner area in each well is 0.7cm2.  
(Compare to Figure 2-13c)  
 
2.4.6 Descriptions of infected fibrin clots with higher fibrin concentration 
In Figure 2-18, with the same cell concentration in a four-fold concentrated fibrinogen solution 
(2mg/ml), the shape of the two-step bulk rheology curve is maintained and the final bulk 
elasticity was greater than the pure fibrin clot. However, the difference between the pure and 
infected fibrin steady-state G/ value is reduced and the inflection point of the infected clot curve 
comes later. Specifically, the 2mg/ml infected fibrin curve first increases rapidly as the 
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polymerization occurs and then attains a plateau (23.0 ± 4.4 Pa) that is slightly lower than pure 
fibrin (30.6 ± 2.4 Pa) until 100 min, when there is a sudden increase in G/. The clot reaches its 
steady-state G/	value (65.8±7.8 Pa), which is about 2.2 times greater than for pure fibrin. In 
Figure 2-19, mesoscopic heterogeneity was observed in both 1.0mg/ml and 1.5mg/ml infected 
clots within five hours. Within 24 hours, the 1.0mg/ml and 1.5mg/ml infected clots show 
macroscopic heterogeneity. Neither macroscopic nor mesoscopic ruptures were observed with 
the specified cell concentration in the 2.0mg/ml infected clots within 24 hours.  
 
	
Figure 2-18 Infected fibrin clot at 2mg/ml 
Linear elastic modulus, G’, as a function of time for different fibrinogen (Fg) concentrations 
(0.5mg/ml and 2mg/ml) and with (red and orange) and without (black and grey) S. epidermidis 
cells (4×109cells/ml). Error bars denote standard error of the mean of n = 3.   
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Figure 2-19 | Infected clot rupturing events 
 (Left panel): 3D confocal laser scanning microscopy (CLSM) images of infected clot at five 
hours after clotting with corresponding fibrin concentration to the right panel. Red denotes fibrin, 
blue denotes bacteria. Length of the volume = 128µm.  Height of the volume is 50 µm. Images 
are obtained by stitching four stacks together. (Right panel): Images of infected clots with 
different fibrin concentrations at 6, 12 and 24 hours after clotting. Arrows show the ruptured 
spots. The inner area in each well is 0.7cm2.   
 
2.4.7 A composition model could explain the increased infected clot G’ 
The infected clot demonstrates a bimodal mesh size distribution, which yields a G’ value higher 
than a pure fibrin clot. The large pores in this case are elastically inactive; they would act to 
reduce the elastic modulus of a small mesh size fibrin network by an amount proportional to their 
volume. Here we propose a composition model:  𝐺′uCBavM\ = (1 − ∅\M]^_	`a]_b)𝐺′bBM\\	B_by  eqn (S1) 
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in which 𝐺′uCBavM\ is the experimental elastic modulus of the bimodal infected fibrin network; 𝐺′bBM\\	B_by is the hypothetical homogeneous fibrin network with the small mesh size 
population. The lower bound of the large pore volume fraction is 80 ± 4% (c.f. Figure2-6 and 
Methods). Scanning electron microscopy (Figure 2-20) suggests that the fibrin fiber diameter in 
these regions is unchanged by addition of bacteria. The local elastic modulus of the smaller pore 
size regions of the infected clot is consequently predicted to be 82 ± 63 Pa from eqn (2).  
Combined with the bound on the large pore size, an upper bound on the infected clot elastic 
modulus of 16 ± 13 Pa is predicted by eqn S1, an increase of a factor of 11 ± 9.  The large errors 
of these estimates stem from the large sensitivity of the elastic modulus to the mesh size.  The 
actual increase is a factor of 4 ± 1 from Figure 2-7 and Figure 2-8.  An alternative view is that for 
the model and measurements to be in accord, the large pore volume fraction would need to be 90% ± 9% as compared to the image (lower bound) estimate of 80% ± 4%.  These discrepancies 
could be due to experimental limitations in measuring the large pore volume fraction, an 
indication of the strong sensitivity of fibrin network elastic modulus to fiber radius (Gs ~ r8) and 
mesh size (Gs ~  -5), or a failure of the biomodal model itself.  However, even given the 
discrepancy, the model comparison suggests that effect of the cells on the clot mechanics is to 
open large voids.  These voids have two effects on elasticity that offset each other.  First, the 
voids are effectively elastically inactive.  Second, the voids localize fibrin in dense regions that 
are comparatively stiffer than the cell-free fibrin network.  
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Figure 2-20 | Scanning Electron Microscopy images of an infected fibrin clot 
Spherical objects are S. epidermidis cells attaching to the bottom surface, the fibers connecting 
the cells are fibrin. White square shows the magnified region in the left. The green bar estimates 
the diameter of the fibrin fibers. Images were taken as described in Methods.  
 
2.4.8 Protein-cell interaction could explain the slower clotting kinetics 
In addition to the increasing elastic modulus, the additional of cells also changes the kinetics of 
fibrin structure formation and the infected clot elasticity development. Specifically, the infected 
clots require around twice the time of pure fibrin to reach steady state: 44 min for pure fibrin 
clot; 86 min for infected fibrin clot. Assuming the fibrin polymerization rate depends on the 
reaction rate for thrombin-mediated cleavage of fibrinogen, the process is modeled as:  
   eqn  (S2) 
E + S!
k−1
k1 E i S!
k−2
k2 E + P
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in which, E is the enzyme – thrombin, S is the substrate – fibrinogen, P is the product – cleaved 
fibrinogen molecules, which will then immediately polymerize to fibrin. In this model 34 the time 
to 95% consumption of fibrinogen is: 
                                                        ∆t = 6.s| }: ~(\D@6)IP[SS]                               eqn (S3) 
in which 𝑆6  is the initial substrate concentration, 𝐾B is the Michaelis constant, 𝑘@ is the 
forward reaction rate constant of the second reaction shown in (eqn S2), and 𝐸QaQ  is the total 
concentration of the enzyme. The reaction constants are independent of the presence of bacterial 
cells.  However, the time to reach steady state depends on the protein concentrations – fibrinogen 
or thrombin, which could be altered by their adsorption or binding to the bacterial cell wall.  
 
Estimates suggest that even if all of the cell surface were covered with a fibrinogen monolayer, 
overall fibrinogen solution concentration would decrease by only 1%. Thus, fibrinogen 
adsorption by bacterial does not explain the slower kinetics. On the other hand, if half (0.25U/𝑚𝑙) of the total thrombin concentration is sequestered on cell surfaces, the effective free 
thrombin available for cleaving fibrinogen to form fibrin would drop by an equivalent amount.  
This change would double the time to steady state (eqn S3). This hypothesis is plausible.  First, 
under the conditions of this study, thrombin is reported to be positively charged35 and therefore 
could adsorb on S. epidermidis (zeta potential of -26 ±	2 mV36) due to non-specific electrostatic 
interactions. Second, the bacterial cell surface area is ~ 0.8 𝜇𝑚@ 𝑐𝑒𝑙𝑙.  50% sequestration would 
require only 2% of the total available cell surface area be adsorbed by thrombin37. This coverage 
is reasonable because up to 60% of the staphylococcal cell wall is comprised of wall teichoic 
acids (WTA), which are polyanionic 38. In fact, WTA is reported to be highly associated with 
cationic peptides targeting cell walls 39. Thus, it is plausible that positively charged thrombin 
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molecules are sequestered on the WTA-rich, negatively charged bacterial surfaces, thereby 
impacting the kinetics of infected clot development. 
 
2.5 Discussion 
This study quantifies the significant impact of S. epidermidis on the structure, mechanics, and 
instability of an in vitro model of a blood clot on both microscopic and macroscopic scales. Here 
we consider: (i) potential limitations on the generality of the results; (ii) mechanistic origins of 
the cellular effects on clotting kinetics, elasticity and clot microstructure; (iii) implications of the 
findings for human disease. 
 
A fibrinogen concentration of 0.5 mg/ml was used to produce the model clots; a potential 
limitation of the work is that the fibrinogen concentration in normal human plasma is higher (~ 
2-4 mg/ml)40, and the amount attracted to and polymerized on the device surface could vary. The 
0.5 mg/ml concentration was selected to meet the sensitivity requirements of microrheology and 
to shift the effect of S. epidermidis on fibrin clot formation to within a duration of ten hours.  It 
was, however, possible to study the effect of higher fibrinogen concentrations on elasticity and 
meso/macroscopic structural heterogeneity, so as to assess the generalizability of our results.  
The trends in elastic modulus reported in Figure 2-7 were preserved when the fibrinogen 
concentration was increased to 2 mg/ml (Figure 2-18).  Likewise, macroscopic heterogeneity 
similar to Figure 2-13 was observed when fibrin concentration was increased (Figure 2-19); 
however, in this case much longer observation times were required. 
 
The study design recognizes: (i) the need to deconstruct the multiple interactions that occur in 
physiological infected clots; (ii) the centrality of bacteria-fibrin interactions to infected clot 
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stability because of the primary role of fibrin in clot mechanics; (iii) the spectrum of choices 
available to study the bacteria-fibrin interaction.  As discussed in the Introduction, the present 
research represents a limiting case in which bacterial cell attachment and replication are 
eliminated from the study design.  The high bacterial cell concentrations used in the study are 
appropriate because they are representative of conditions found in vivo, for infected clots in an 
animal model (22).     
 
Our identification of these elements in the study design provides a roadmap for future work to 
generate full mechanistic understanding of infected clots under physiological conditions. That is, 
each of the three conditions in our initial deconstruction could be revisited. Such work would 
address the additional interactions generated by other blood constituents, particularly platelets.  It 
would bridge between the present study – focused on the bacteria-fibrin interaction – and results 
on infected clots under physiological conditions (e.g. as in recently reported in Davies et al) 41.  
 
The elastic modulus of the model clot could change if the added bacterial cells induce structural 
changes in the fibrin network itself.  A well-tested model of the fibrin network elastic modulus 
finds that: 
                                             Gb = LPP]IJK9 	                                       (equation 2) 
where E is the Young’s modulus of a single fibrin fiber, r is the fiber radius, and ξ is the network 
mesh size13,42 43.  Unligated fibrin fibers have bending Young’s modulus E ~2MPa 25 13 44, A 
0.5mg/ml fibrin network has an average fiber radius r ~ 36 nm14.  With the pure fibrin network 
mesh size 𝜉	= 5.9𝜇𝑚 (c.f. Figure 2-9), equation (2) yields a predicted steady-state elastic 
modulus of 1.4 Pa; this prediction is in agreement with the Figure 2-7 report of 1.5 ± 0.2 Pa. 
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The infected clot exhibits a bimodal mesh size distribution with average mesh sizes of 23  m 
and 2.6  m.  Because of the strong inverse relationship between modulus and mesh size (Gs ~  -
5), the large pore regions are effectively elastically inactive.  These regions therefore decrease the 
infected clot modulus in proportion to their volume fraction.  On the other hand, the fibrin 
network in the infected clot has a higher elastic modulus; some regions are enriched in fibrin 
relative to the pure fibrin clots as evidenced by their relatively smaller pore size population. 
Calculations (c.f. Figures 2-6, 2-20) show that the offsetting contributions of the higher local 
elastic modulus of the smaller pore size regions and the elastically inactive regions of large pore 
size could explain the observed increase of the infected clot elastic modulus. That is, the analysis 
suggests that the effect of the cells on the clot mechanics could be to open large voids; these 
voids localize fibrin in dense regions that are comparatively stiffer than the cell-free fibrin 
network.  
 
The additional of cells also changes the kinetics of fibrin structure formation and the clot 
elasticity development. Interactions between host proteins and pathogenic bacteria could 
generate these effects by reducing the effective concentration of either fibrinogen monomer or 
thrombin enzyme available for fibrinogen polymerization. In fact, estimates suggest that 
fibrinogen adsorption by bacteria does not explain the slower kinetics. However, if half (0.25U/𝑚𝑙) of the total thrombin concentration is sequestered on cell surfaces, the effective free 
thrombin available for cleaving fibrinogen to form fibrin would drop by an equivalent amount.  
Thrombin adsorption to the bacterial surface is consistent with both the charge state and 
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composition of the S. epidermidis cell wall.  Reduced concentration of free thrombin would 
explain the observed retardation kinetics of clot formation.  
 
Previously, colloidal particles have been used to study the influence of micrometer-scale objects 
on fibrin structure 45. To evaluate the potential relevance of such findings to the above 
hypothesis, we performed the following control experiment: Bacterial cells were replaced with 
0.5  m polystyrene particles, incubated in two different concentrations of Bovine Serum 
Albumin (BSA).  In Figure 2-21, we show that low-BSA (0.5%, incubated for 24 hours) coated 
particles influence the clot structure in a similar way to S. epidermidis bacterial cells.  On the 
other hand, high-BSA (15%, incubated for more than a month) coated particles do not create a 
heterogeneous fibrin structure, functioning instead as an inert, micron-scale filler. Thus, particle 
surface chemistry appears to be a determinant of whether or not added cells/objects affect fibrin 
structure.  Particle/cell surface chemistry could affect fibrin polymerization through its role in 
surface-adsorption of thrombin, fibrinogen and/or fibrin oligomers onto the particles/cells, as we 
earlier hypothesized.  The control experiments suggest that the bacterial effect on fibrin structure 
is mediated by the surface properties of the cells, rather than just by the fact that the cells take up 
volume in the network. 
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Figure 2-21 | Fibrin Structure influenced by micrometer-scale objects 
Axial projections of fibrin formed in the presence of 0.5 m m carboxylate conjugated polystyrene 
particles incubated in (a) 0.5% bovine serum albumin (BSA) solution for 24 hours; (b) 15% BSA 
solution for more than a month. Fibrin is red, colloidal particles are light blue. Comparison to 
Figure 2-9 shows that the fibrin structure in (a) is similar to that of introduced bacteria in terms 
of the distinct heterogeneity in pore size distribution -- large pores and small pores; however, the 
fibrin structure in (b) does not have the same structure as Figure 2-9.  The zeta-potential of the 
two particles are -24 ± 2 mV (a) and – 11 ± 6 mV (b), respectively.  The results show that 
particle surface chemistry and surface charge are correlated with the self-assembled fibrin 
structure. 
 
This fundamental study of the influence of S. epidermidis cells on fibrin kinetics, structure and 
instability simplifies the conditions of physiological clotting so as to directly identify bacterial – 
fibrin interactions.  A recent study under physiological conditions by Davies et al. (35) showed 
that clot structure and mechanics change with the different stages of sepsis.  Common features of 
the two studies are the observed correlation of microstructure and mechanical properties.  Our in 
vitro study sheds light on the underlying physical and biochemical mechanisms that link fibrin 
kinetics with bacterial cells. Future work could address the role that other physiological 
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constituents – serum proteins and platelets in particular – play in mediating the effect that 
bacteria has on clot structure and mechanics. 
 
This study addressed the structure, mechanics, and instability of an in vitro blood clot model 
infected by S.epidermidis from microscopic and macroscopic perspectives. It has potential 
clinical implications: the result that S. epidermidis cells slow down the fibrin clotting process has 
potential connections to infection-related hemostatic diseases. The fact that the infected clot 
which formed in the presence of bacteria exhibits a higher elasticity has implications for embolic 
diseases which have been correlated with high fibrin rigidity46,47 – a clinical indicator used to 
determine the appropriate therapy for venous thrombosis treatment13,14. Furthermore, this study 
presents evidence suggesting that S. epidermidis remodels host fibrin network, leading to clot 
rupture, the detailed kinetics of which could be the subject of future study.  This relationship 
provides insight into the correlation between bacterial infection and thromboembolism. By 
identifying S.epidermidis effects on fibrin networks, it opens up discussion of the interaction 
mechanisms between bacteria and embolism with potential implications for treating septic 
thromboembolism. The infected clot model could also be used to study other situations – such as 
chronic wound healing and scar formation – in which bacteria and clot co-present in the human 
body.  
 
2.6 Acknowledgement 
 
We thank John G. Younger for early collaboration and project conceptualization. We also thank 
Usha Kadiyala for the help with taking the scanning electron microscopy image. This work is 
supported by NIH NIGMS (Grant GM-081702).  
 
58 
2.7 References: 
 
1 Arnold, M. et al. Thrombolysis in patients with acute stroke caused by cervical artery 
dissection: analysis of 9 patients and review of the literature. Archives of neurology 59, 549-553 
(2002). 
 
2 Tapson, V. F. Acute pulmonary embolism. The New England journal of medicine 358, 
1037-1052, doi:10.1056/NEJMra072753 (2008). 
 
3 Samama, M. M. An epidemiologic study of risk factors for deep vein thrombosis in 
medical outpatients: the Sirius study. Archives of internal medicine 160, 3415-3420 (2000). 
 
4 Dalager-Pedersen, M. et al. Venous thromboembolism after community-acquired 
bacteraemia: a 20-year danish cohort study. PLoS One 9, e86094, 
doi:10.1371/journal.pone.0086094 (2014). 
 
5 Grau, A. J. et al. Clinical and biochemical analysis in infection-associated stroke. Stroke; 
a journal of cerebral circulation 26, 1520-1526 (1995). 
 
6 Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Bacterial biofilms: from the Natural 
environment to infectious diseases. Nat Rev Micro 2, 95-108 (2004). 
 
7 Raad, II et al. The relationship between the thrombotic and infectious complications of 
central venous catheters. Jama 271, 1014-1016 (1994). 
 
8 Brackman, G., De Meyer, L., Nelis, H. J. & Coenye, T. Biofilm inhibitory and 
eradicating activity of wound care products against Staphylococcus aureus and Staphylococcus 
epidermidis biofilms in an in vitro chronic wound model. Journal of applied microbiology 114, 
1833-1842, doi:10.1111/jam.12191 (2013). 
 
9 Lordick, F. et al. Ultrasound screening for internal jugular vein thrombosis aids the 
detection of central venous catheter-related infections in patients with haemato-oncological 
diseases: a prospective observational study. British journal of haematology 120, 1073-1078 
(2003). 
 
10 Kim, M. K., Ingremeau, F., Zhao, A., Bassler, B. L. & Stone, H. A. Local and global 
consequences of flow on bacterial quorum sensing. Nat Microbiol 1, 15005, 
doi:10.1038/nmicrobiol.2015.5 (2016). 
 
11 Peterson, B. W. et al. Viscoelasticity of biofilms and their recalcitrance to mechanical 
and chemical challenges. FEMS Microbiol Rev 39, 234-245, doi:10.1093/femsre/fuu008 (2015). 
12 VanEpps, J. S. & Younger, J. G. Implantable Device-Related Infection. Shock (Augusta, 
Ga.) 46, 597-608, doi:10.1097/shk.0000000000000692 (2016). 
 
 
59 
13 Piechocka, I. K., Bacabac, R. G., Potters, M., Mackintosh, F. C. & Koenderink, G. H. 
Structural hierarchy governs fibrin gel mechanics. Biophys J 98, 2281-2289, 
doi:10.1016/j.bpj.2010.01.040 (2010). 
 
14 Ryan, E. A., Mockros, L. F., Weisel, J. W. & Lorand, L. Structural origins of fibrin clot 
rheology. Biophysical Journal 77, 2813-2826 (1999). 
 
15 Weisel, J. W. Structure of fibrin: impact on clot stability. Journal of Thrombosis and 
Haemostasis 5, 116-124, doi:10.1111/j.1538-7836.2007.02504.x (2007). 
 
16 Janmey, P. A., Winer, J. P. & Weisel, J. W. Fibrin gels and their clinical and 
bioengineering applications. J R Soc Interface 6, 1-10, doi:10.1098/rsif.2008.0327 (2009). 
 
17 Otto, M. Staphylococcus epidermidis--the 'accidental' pathogen. Nat Rev Microbiol 7, 
555-567, doi:10.1038/nrmicro2182 (2009). 
 
18 McCann, M. T., Gilmore, B. F. & Gorman, S. P. Staphylococcus epidermidis device-
related infections: pathogenesis and clinical management. The Journal of pharmacy and 
pharmacology 60, 1551-1571, doi:10.1211/jpp.60.12.0001 (2008). 
 
19 Wisplinghoff, H. et al. Nosocomial bloodstream infections in US hospitals: analysis of 
24,179 cases from a prospective nationwide surveillance study. Clinical infectious diseases : an 
official publication of the Infectious Diseases Society of America 39, 309-317, 
doi:10.1086/421946 (2004). 
 
20 Prasad, J. M. et al. Mice expressing a mutant form of fibrinogen that cannot support 
fibrin formation exhibit compromised antimicrobial host defense. Blood 126, 2047-2058, 
doi:10.1182/blood-2015-04-639849 (2015). 
 
21 Loof, T. G. et al. Staphylococcus aureus-induced clotting of plasma is an immune 
evasion mechanism for persistence within the fibrin network. Microbiology 161, 621-627, 
doi:10.1099/mic.0.000019 (2015). 
 
22 Lungren, M. P. et al. Bacteriophage K antimicrobial-lock technique for treatment of 
Staphylococcus aureus central venous catheter-related infection: a leporine model efficacy 
analysis. J Vasc Interv Radiol 25, 1627-1632, doi:10.1016/j.jvir.2014.06.009 (2014). 
 
23 Whiting, D. & DiNardo, J. A. TEG and ROTEM: Technology and clinical applications. 
American Journal of Hematology 89, 228-232, doi:10.1002/ajh.23599 (2014). 
 
24 Evans, P. A. et al. Rheometry and associated techniques for blood coagulation studies. 
Medical engineering & physics 30, 671-679, doi:10.1016/j.medengphy.2007.08.005 (2008). 
 
25 Collet, J.-P., Shuman, H., Ledger, R. E., Lee, S. & Weisel, J. W. The elasticity of an 
individual fibrin fiber in a clot. Proceedings of the National Academy of Sciences of the United 
States of America 102, 9133-9137, doi:10.1073/pnas.0504120102 (2005). 
 
60 
26 Bendix, P. M. et al. A Quantitative Analysis of Contractility in Active Cytoskeletal 
Protein Networks. Biophysical Journal 94, 3126-3136, doi:10.1529/biophysj.107.117960 (2008). 
 
27 Utada, A. S. et al. Vibrio cholerae use pili and flagella synergistically to effect motility 
switching and conditional surface attachment. Nat Commun 5, 4913, doi:10.1038/ncomms5913 
(2014). 
 
28 Valentine, M. T. et al. Colloid Surface Chemistry Critically Affects Multiple Particle 
Tracking Measurements of Biomaterials. Biophysical Journal 86, 4004-4014, 
doi:10.1529/biophysj.103.037812 (2004). 
 
29 Billings, N., Birjiniuk, A., Samad, T. S., Doyle, P. S. & Ribbeck, K. Material properties 
of biofilms-a review of methods for understanding permeability and mechanics. Rep Prog Phys 
78, 036601, doi:10.1088/0034-4885/78/3/036601 (2015). 
 
30 Savin, T. & Doyle, P. S. Static and dynamic errors in particle tracking microrheology. 
Biophys J 88, 623-638, doi:10.1529/biophysj.104.042457 (2005). 
 
31 Stewart, E. J., Ganesan, M., Younger, J. G. & Solomon, M. J. Artificial biofilms establish 
the role of matrix interactions in staphylococcal biofilm assembly and disassembly. Sci Rep 5, 
13081, doi:10.1038/srep13081 (2015). 
 
32 Squires, T. M. & Mason, T. G. Fluid Mechanics of Microrheology. Annual Review of 
Fluid Mechanics 42, 413-438, doi:doi:10.1146/annurev-fluid-121108-145608 (2010). 
 
33 Squires, T. M. & Mason, T. G. Fluid Mechanics of Microrheology. Annual Review of 
Fluid Mechanics 42, 413-438, doi:10.1146/annurev-fluid-121108-145608 (2009). 
 
34 Michaelis, L., Menten, M. L., Johnson, K. A. & Goody, R. S. The original Michaelis 
constant: translation of the 1913 Michaelis-Menten paper. Biochemistry 50, 8264-8269, 
doi:10.1021/bi201284u (2011). 
 
35 Mommaerts, W. F. H. M. ON THE NATURE OF FORCES OPERATING IN BLOOD 
CLOTTING : II. THE CLOTTING OF FIBRINOGEN AS A TWO-STEP REACTION. The 
Journal of General Physiology 29, 113-122 (1945). 
 
36 McGuffie, M. J. et al. Zinc oxide nanoparticle suspensions and layer-by-layer coatings 
inhibit staphylococcal growth. Nanomedicine : nanotechnology, biology, and medicine 12, 33-
42, doi:10.1016/j.nano.2015.10.002 (2016). 
 
37 Fischer, H., Polikarpov, I. & Craievich, A. F. Average protein density is a molecular-
weight-dependent function. Protein Science : A Publication of the Protein Society 13, 2825-
2828, doi:10.1110/ps.04688204 (2004). 
 
38 Brown, S., Santa Maria, J. P., Jr. & Walker, S. Wall teichoic acids of gram-positive 
bacteria. Annu Rev Microbiol 67, 313-336, doi:10.1146/annurev-micro-092412-155620 (2013). 
 
61 
39 Weidenmaier, C. & Peschel, A. Teichoic acids and related cell-wall glycopolymers in 
Gram-positive physiology and host interactions. Nat Rev Microbiol 6, 276-287, 
doi:10.1038/nrmicro1861 (2008). 
 
40 Tennent, G. A. et al. Human plasma fibrinogen is synthesized in the liver. Blood 109, 
1971-1974, doi:10.1182/blood-2006-08-040956 (2007). 
 
41 Davies, G. R. et al. The effect of sepsis and its inflammatory response on mechanical clot 
characteristics: a prospective observational study. Intensive care medicine 42, 1990-1998, 
doi:10.1007/s00134-016-4496-z (2016). 
 
42 van Kempen, T. H., Bogaerds, A. C., Peters, G. W. & van de Vosse, F. N. A constitutive 
model for a maturing fibrin network. Biophys J 107, 504-513, doi:10.1016/j.bpj.2014.05.035 
(2014). 
 
43 MacKintosh, F. C., Kas, J. & Janmey, P. A. Elasticity of semiflexible biopolymer 
networks. Phys Rev Lett 75, 4425-4428, doi:10.1103/PhysRevLett.75.4425 (1995). 
 
44 Liu, W., Carlisle, C. R., Sparks, E. A. & Guthold, M. The mechanical properties of single 
fibrin fibers. Journal of thrombosis and haemostasis : JTH 8, 1030-1036, doi:10.1111/j.1538-
7836.2010.03745.x (2010). 
 
45 Bharadwaj, N. A. et al. Integration of colloids into a semi-flexible network of fibrin. Soft 
Matter 13, 1430-1443, doi:10.1039/c6sm02141g (2017). 
 
46 Collet, J. P. et al. Dusart syndrome: a new concept of the relationship between fibrin clot 
architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. 
Blood 82, 2462-2469 (1993). 
 
47 Collet, J. P. et al. Influence of fibrin network conformation and fibrin fiber diameter on 
fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler 
Thromb Vasc Biol 20, 1354-1361 (2000). 
 
 
  
 
62 
 
3 Chapter 3: Growth-dependent bacteria-fibrinogen interaction and infected 
fibrin formation2 
 
3.1 Abstract:  
Bacterial infection and thrombosis are highly correlated, especially in patients with medical 
device implants. Attention has been drawn to the interaction between bacteria and host protein, 
specifically fibrinogen and fibrin. However, little is know regarding the impact of the bacterial 
change from planktonic to biofilm-like phenotype on this interaction. Here we investigate on the 
growth phase dependent bacteria-fibrinogen interaction and bacterial effect on fibrin formation, 
structure and mechanics. Furthermore, this difference is mediated by increased adhesion to 
fibrinogen. Flow cytometry is applied to study the growth-phase dependent bacterial affinity for 
fibrinogen. A functional in vitro model was developed to evaluate adhesion of S. epidermidis to a 
fibrinogen coated surface in a continuously flowing environment. The bacterial deposition rate 
onto fibrinogen and residence time on the surface were both significantly greater for stationary 
phase as compared to exponential phase. Furthermore, the gene expression for SdrG – the protein 
that adheres S. epidermidis cells to fibrinogen was significantly increased in the stationary phase. 
Rheometry and confocal microscopy were used to show that stationary phase bacterial cells have 
a more robust effect on fibrin formation, structure and mechanics. We speculate that the stronger 
interaction between stationary phase bacterial cells and fibrinogen could cause the more robust 
																																																						
2	The work of Chapter 3 is in preparation of publication as “Growth-dependent bacteria-fibrinogen 
interaction and infected fibrin formation” by Tianhui Ma, Carolyn Vitale, Janice Sim, Erika Martinez-
Nieves, Michael Solomon, and J. Scott VanEpps  
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effect on fibrin. It contributes to the current understanding of the growth phase dependent 
regulation of bacterial virulent factors and the correlation between bacterial infection and 
thrombosis. 
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3.2 Introduction: 
Pathologic clots, for example, venous thromboembolism and embolic cerebrovascular accidents, 
are highly correlated with bacterial infection(1-4). Clinically, thrombosis and bacterial biofilms 
often appear simultaneously, especially on implanted medical devices(1, 5). One study showed 
that 12 of 14 patients with central venous catheter (CVC) related infection had a preceding CVC 
related venous thrombosis (6) and a relative risk of thrombosis is assigned to the presence of 
infection (7). One of the mechanisms to explain such correlation is that clotting proteins provide 
a substrate for bacterial adherence with microbial receptor-specific binding to fibrinogen and its 
cleaved product fibrin. Specifically, Staphyloccocus epidermidis has a well described surface 
protein called SdrG which binds fibrinogen in a “lock, dock and latch” mechanism (8-11). Given 
its specific binding of the coagulation protein fibrinogen, SdrG is a plausible key protein 
mediating the interaction between infection and thrombosis.  
 
A biofilm is a bacterial community that occurs when bacteria attach to a surface, alter their 
phenotype and produce a protective layer of extracellular polymeric substance (EPS). A 
significant cause of clinical infections, biofilms present a significant obstacle to host immune 
defense, mechanical debridement, and treatment with traditional antimicrobials(12) The most 
commonly recognized biofilm infections are those related to indwelling medical devices(13). 
The life cycle of a biofilm begins when bacteria adhere to a surface followed by an initially 
period of exponential growth and EPS production. Once the biofilm becomes densely populated 
and encased in EPS, the bacteria slow their growth to a stationary phase. Finally, some of the 
bacteria detach as planktonic (i.e., free floating) bacteria to attach and start a new biofilm colony 
elsewhere. Each phase of the life cycle requires specific protein machinery to be most effective 
and the bacteria display phenotypic changes as they progress from planktonic to biofilm 
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phenotype. While the change in phenotype is key in biofilm formation, little is known about the 
impact of these changes on the bacteria-host protein interaction, specifically fibrinogen.   
 
Staphylococcus epidermidis, a ubiquitous commensal colonizer of human skin, belongs to the 
group of coagulase negative Staphylococcal species which are the leading cause of device related 
infection, endocarditis and surgical site infections (14, 15). Device related infections, particularly 
central line associated bloodstream infections increase mortality, medical cost and hospital 
length of stay (16, 17).  
 
Previous work from our lab showed that not only bacteria adhere to fibrin clots, their presence 
also influence the clot microstructure and mechanics in a way that has implications for bacterial 
induced thromboembolism (18). The goal of this research is to explore the phenotypic 
differences between stationary and exponential phase bacteria in the scope of their interactions 
with fibrinogen and their impact on thrombus characteristics, specifically fibrin formation, 
structure and mechanics. We first applied flow cytometry to characterize the growth-phase 
dependent bacterial affinity for fibrinogen. We then evaluated phase dependent S.epidermidis 
affinity for fibrinogen in solution and separately the surface based deposition of bacteria onto 
fibrinogen in a continuously flowing model mimicking blood flow. Next, we compared phase 
differences in gene expression of bacterial cell surface proteins with potential impact on 
adhesion and interaction with host coagulation proteins. We performed rheology and evaluated 
structure of S. epidermidis infected fibrin clots. 
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3.3 Materials and methods:  
3.3.1 Bacterial strains and culture:  
S. epidermidis strain RP62A, a pathogenic strain which forms biofilms, was used for all 
experiments. Loop inoculates from frozen glycerol stock (-80°C) were grown on Tryptic Soy 
Agar (TSA, Fisher Scientific) plates for at least 16 hours at 37°C. A single colony was selected 
and cultured in Tryptic Soy Broth with glucose 1% (TSBG) at 37°C under agitation at 200-250 
rpm.  Exponential phase growth was defined as an optical density of 0.4 ± 0.1 measured at 600 
nm. A 30 mL sample of culture was removed and left undisturbed for 30 -60min at room 
temperature to allow for settling of flocculated cells. For the model of bacterial deposition onto 
fibrinogen mimicking medical device infection and the flow cytometry experiment, the culture 
was returned to incubator at 37°C to continue growth under agitation until optical density of 1.4 
(± 0.05) at 600 nm which defined stationary phase growth. For the rheometry experiments, a 
separate culture was grown to the stationary phase growth as defined previously.  
 
3.3.2 Quantification of surface fibrinogen by flow cytometry:  
S. epidermidis were cultured to exponential and stationary phase growth as defined and described 
above. Cell density  was quantified in each sample with Incyto Hemacytometer (Thermo Fisher 
Scientific, Waltham, MA, USA) and cells were centrifuged into a pellet at 5000 xg for 3 minutes. 
Supernatant was discarded, and pelleted cells were diluted to concentration of 2x109 cells/mL. 
Two conditions were prepared in triplicate for each culture—control and labeled fibrinogen. 
Control sample and labeled fibrinogen pellets were resuspended in Hank’s Buffered Salt solution 
1X (with Calcium, Magnesium, no phenol red, 1g/L D-Glucose, Thermo Fisher Scientific, 
Waltham, MA, USA . Fluorescently labeled fibrinogen (Alexafluor 647 Fibrinogen, 650/668nm, 
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Thermo Fisher Scientific, Waltham, MA, USA ) was added to each sample for final 
concentration of 0.5 mg/mL and incubated for 15 minutes. Cells were then analyzed by flow 
cytometry (Cytoflex, Beckman). Mean fluorescence was determined as a surrogate for total 
fibrinogen concentration on the cell surface using FCS Express (Denovo). A total of 9 
experiments were completed in triplicate with the mean from each experiment used for analysis. 
Statistical analyses was performed with Wilcoxon paired signed rank test with significance 
defined as p < 0.05.  
 
3.3.3 Bacterial adhesion to fibrinogen in continuously flowing environment:  
Fibrinogen (Fg) from human plasma (EMD Millipore Corporation, Billerica, MA, USA) was 
reconstituted as directed and stored at -80°C in aliquots. Frozen aliquots were thawed and diluted 
to concentration of 10 µg/mL using sterile distilled water. Glass coverslips were coated with 
fibrinogen for 4 hours at 20°C, blocked with 1% bovine serum albumin for 1 hour followed by 
three washes with normal saline.  
 
The stationary phase sample was diluted with normal saline to match optical density of the 
exponential phase culture then left undisturbed at 20°C for one hour. Exponential stationary 
phase cells were fluorescently labeled with Syto 9 (Thermo Fisher Scientific, Waltham, MA, 
USA). Cells were loaded into a 10 mL syringe on a standard syringe pump (Harvard Apparatus). 
Fibrinogen coated glass coverslips were constructed into a parallel plate flow chamber (Harvard 
Apparatus). Cell suspensions were infused at a rate of 125 µL/min through parallel plate flow 
chamber mounted on a epifluorescent microscope with high speed microvideography 
capabilities.  Images were captured every 3 seconds for 30 minutes. A total of 10 experiments 
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were completed in duplicate and the mean for each experiment was used. Image analysis was 
completed in MATLAB. A new adhesion event was defined as the new appearance of a bacteria 
which persisted for two or more images in a single location. Residence time was defined as the 
total time a signle bacteria persisted at a single location. Wilcoxon signed-rank test was used for 
nonparametric hypothesis testing comparing deposition rate, expressed as cells/cm2 s versus 
growth phase. For residence time, a Kruskal-Wallis test was used to compare the population of 
bacteria persisting for greater than 500 seconds for each growth phase with significance defined 
as p < 0.001.  
 
3.3.4 Gene expression changes from exponential to stationary phase:  
RNA was extracted from S. epidermidis grown to either exponential or stationary phase as 
described above. One mL of liquid bacterial cultures was grown to centrifuged at 8000 rpm for 1 
minute to pellet the cells. After washing with RNase free water, cells were resuspended. Cell 
lysis was achieved with 5 µl lysostaphin (2ug/µl), incubation at 37°C for 45min to an hour 
followed by addition of 75µl TRIzol and vigorous pipetting. Samples were vortexed and then 
centrifuged at 12000 rpm for 10 minutes at 4°C. Supernatant was removed and incubated at 
room temperature for 5 minutes. Chloroform (15µl) was added to the sample, vortexed for 15 
seconds, and incubated at room temperature for 3 minutes. Following this, samples were 
centrifuged at 12000 rpm for 15 minutes at 4°C. The aqueous phase was isolated and transferred 
to using the RNeasy Mini Kit spin columns (Qiagen) and RNA was purified per the 
manufacturer’s instructions.  High quality RNA yield was confirmed by UV spectrophotometry 
and Bioanalyzer.  Samples were stored at -80°C.QuantiTect Probe RT-PCR (Qiagen) was utilized 
in 50 µl reactions. The reaction mixture contained 25 µl 2x Probe RT-PCR Master Mix, 0.5 µl 
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RT Mix, 5 µl of Exponential Phase or Stationary Phase (Ep/Sp) RNA template (5 ng), and 5 µl of 
each gene forward/reverse-primer (F/R-primer, 1 uM) and probe-primer (0.2 uM); finally, 
amplification mixture was set to 50 µl by adding 4.5 µl of RNase-free water. The RT-PCR 
Master Mix contained HotStarTaq DNA polymerase, ROX reference dye, dNTP mix, and RT-
PCR buffer (Tris-Cl, KCl, (NH4)SO4, 8 mM MgCl2, at pH 8.7). Thermal cycling protocol began 
with 30 minutes in the reverse transcription step at 50°C, followed by an initial activation step of 
15 minutes at 95°C, denaturation of 15 seconds at 94°C, and combined annealing/extension step 
at 65°C for 60 seconds for a total of 45 cycles.  
 
3.3.5 Mechanics and microstructure measurements of fibrin clots:  
Materials and constitution methods are described in previously published work (18). Briefly, 
Citrate-free thrombin from human plasma and fibrinogen (Fg) from human plasma were 
purchased from EMD Millipore (Billerica, MA). Fibrinogen solutions (0.5mg/ml) were made by 
diluting the stock solution with Hank’s Balanced Salt Solution at 37°C. Clot was initiated by 
adding thrombin (0.5U/ml as final concentration). 
Clot elasticity was characterized by measuring the linear elastic modulus, G', on a mechanical 
rheometer (TA Instruments AR-G2, cone and plate fixture with a 2° cone angle and a 40 mm 
diameter); clot microstructures were observed using a Nikon A1Rsi confocal laser scanning 
microscope with a 100x, 1.45 NA, oil immersion objective  and images were analyzed to 
determine mesh size using Matlab as we have previously described (18). The steady state of 
fibrin structures is defined as those that are 50 – 90min from the initiation of clot formation as 
explained in our previous work (18). Bacteria concentration for both exponential and stationary 
phase were 4 × 109 cells/ml to match the in vivo biofilm concentration. 
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3.4 Results:  
3.4.1 Stationary phase S. epidermidis cell surface binds more fibrinogen 
Figure 3-1a shows an example of a single experiment with exponential phase in black and 
stationary phase in red. The fluorescence of stationary phase is higher than exponential phase 
with a similar distribution. Composite mean fluorescence index of all experiments (n= 9 in 
triplicate) is shown in Figure 3-1b. The mean fluorescence of stationary phase bacteria incubated 
with fluorescently labeled fibrinogen was significantly higher as compared to exponential phase 
bacteria under the same condition (3642 ± 349 vs 6388 ± 919, n=10, p = 0.004) as seen in Figure 
3-1b.   
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 (a) Example of single experiment with fluorescence versus event count. (b) Mean fluorescence 
of S. epidermidis in exponential phase versus stationary phase growth with a bacterial cell 
concentration of 4×109cells/ml and fibrin concentration of 0.5mg/ml. n = 9 of paired experiments 
in triplicate. Data was collected by Carolyn Vitale. 
 
3.4.2 Stationary phase S. epidermidis cells has a stronger attraction to fibrinogen 
Fluorescent labeled bacteria were visualized in image capture flowing past immobilized 
fibrinogen (Figure 3-2a-e), appearing as streaks on image capture but clearly defined circular 
shape as they slow and rest on the surface. Persistence of a bacteria in a single location for 
Figure 3-1 | Flow cytometry of bacteria incubated with 
fluorescently labeled fibrinogen 
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multiple images defined an adhesion event (white box in Figure 3-2b-d) while subsequent 
absence of an adhered bacteria (white box Figure 3-2f) defined a release event and the total time 
spent adhered was defined as residence time. The deposition rate of bacterial cells on 
immobilized fibrinogen showed a steady, linear relationship for both exponential and stationary 
phase bacteria (Figure 3-2f); however, the deposition rate of stationary phase cells was 
significantly greater than the deposition rate of cells in exponential phase (5360 ± 1776 vs 2212 
± 264, n=10, p < 0.05) (Figure 3-2g).  Additionally, stationary phase bacteria showed a 
significantly longer residence time when compared to exponential phase cells (Figure 3-2h). 
Most notably there was a population of stationary phase cells that had a residence time of greater 
than 500 seconds, skewing the distribution to the right as compared to the exponential phase 
bacteria. That is, only 2.7% of exponential cells had a residence time of greater than 500 seconds 
while 13.1% of the stationary phase cell had a residence time greater than 500 seconds.  This 
difference is also significant (Chi-squared, p<0.001). 
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Figure 3-2 | Adhesion of S. epidermidis to a fibrinogen coated surface under a continuously 
flowing environment 
 (a-e) Images captured 3 seconds apart of fluorescently labeled fibrinogen (green) with absence 
of bacteria in white frame in (a), adhesion in frames (b-d) and absence in (e) representing a 
release event. Time between frames (b) to (e) represents the residence time of that single bacteria.  
(f) Graphical representation of a single experiment of adhesion events over time with exponential 
phase bacteria (red) versus stationary phase (blue). (g) Adhesion rate of exponential phase (red) 
versus stationary phase (blue) S. epidermidis with n = 10 of paired experiments in duplicate. (h) 
Residence time of exponential phase (red) versus stationary phase (blue) S. epidermidis with n = 
10 of paired experiments in duplicate. Data was collected by Carolyn Vitale. 
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3.4.3 Stationary phase S. epidermidis cells express more fibrinogen-binding 
proteins 
The RNA expression of SdrG (2.16 ± 0.91) and Sspa (3.43 ± 1.83), described in fold-change in 
stationary phase compared to exponential phase bacteria, were significantly elevated in 
stationary phase bacteria as compared to the expression in exponential phase bacteria (Figure 3-
3).  The expression of Aap (2.15 ± 1.1), Atle (1.11 ± 0.65), Ica (1.62 ± 0.85) and SdrF (1.21 ± 
0.83) all showed non-significant increase in expression in stationary phase bacteria. There was a 
significant decrease in IcaR (0.743 ± 0.15) expression in stationary phase as compared to 
exponential phase bacteria. Analysis done with a paired t-test with Bonferroni correction for 
multiple comparisons.  p<0.05 indicated by *.  
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Figure 3-3 | RT-PCR of S. epidermidis proteins 
(a) Fold change in expression of stationary phase bacteria as compared to exponential phase 
bacteria. Error bars represent standard error of the mean with n = 7. RNA samples were extracted 
by Janice Sim and RT-PCT was performed by Erika Martinez-Nieves. (b) S. epidermidis proteins 
and their function. 
 
3.4.4 The mechanical and structural effect of S. epidermidis on fibrin clots growth-
phase dependent 
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The elasticity of a pure fibrin clot (0.5 mg/ml fibrinogen) without bacterial cells increases rapidly 
and reaches a steady-state value of 1.5 ± 0.2 Pa in ~40 min (Figure 3-4a). The addition of 
stationary phase bacterial cells has a significant effect on the kinetics of the fibrin clot elastic 
response: Clot formation is initially retarded and has a transient plateau at a modulus value less 
than the steady-state modulus of the pure fibrin clot. Then the elastic modulus rapidly increases 
to a second steady-state value ~4 times greater than that of the pure fibrin clot. Contrarily, the 
addition of the exponential phase bacterial cells of the same cell concentration has a less 
significant effect on fibrin kinetics. Initially, the process is also retarded but it then reaches its 
final plateau at a modulus value lower than that of the pure fibrin.  
 
Figure 3-4b and c compare the steady-state structure (c.f. Methods) of the corresponding 
conditions with the fibrin elasticity measurements. The pure fibrin network has a homogeneous 
pore size distribution. The pure fibrin mesh size (c.f. Methods) – the average distance between 
fibers – is 5.9±1.1 µm (Figure 3-4c), consistent with previous measurements in the literature(19). 
On the other hand, the network formed in the presence of stationary phase S. epidermidis is 
heterogeneous with two characteristic mesh size as reported by our group previously (18). 
However, the fibrin network structure formed in the presence of exponential phase bacterial cells 
(7.1 ± 1.5 µm) remains homogeneous and the mesh size becomes larger than the pure fibrin (p < 
0.001).  The exponential phase bacterial cells are visualized in the voids of the fibrin network. 
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Figure 3-4 | Stationary Phase S. epidermidis Alters Fibrin Elasticity and Structure 
 (a) Time sweep of elastic modulus, G’, of pure fibrin clot (0.5mg/ml) (black) and fibrin clots 
infected by stationary phase bacterial cells (red), exponential phase bacterial cells (green) and 
stationary phase bacterial cells incubated with BSA (orange) (0.5mg/ml fibrin with 
4×109cells/ml). Error bars denote standard deviation with n=3. (b) Mesh size characterization of 
steady state pure fibrin clot and infected fibrin clot. Error bars denote standard deviations of all 
the image stacks in all five replicates (c.f. Methods). Scale bar = 10µm. (c) Axial projections of a 
pure fibrin clot, (d) a fibrin clot infected with exponential phase bacterial cells. Images were 
collected by Janice Sim. (e) Stationary phase bacterial cells and (f) Stationary phase bacterial 
cells incubated with BSA. Bacterial cell concentrations are all 4×109cells/ml and fibrin 
concentration is 0.5mg/ml. Fibrin is red and bacterial cells are blue.  
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3.5 Discussion: 
This study demonstrates the growth phase dependent bacterial fibrinogen interactions. We further 
elucidated the growth phase dependent effect of bacteria on fibrin formation, mechanics and 
structure. Specifically, S.epidermidis in its stationary phase expresses more SdrG, has increased 
affinity for fibrinogen, adheres more and for a longer duration to a fibrinogen coated surface and 
generates a heterogeneous fibrin clot network structure that is four times higher in stiffness; on 
the contrary, S.epidermidis in its exponential phase expresses less SdrG, has a lower fibrinogen 
affinity, with less adhesion to a fibrinogen coated surface and does not have a significant 
influence on fibrin clot structure and mechanics. Here in the discussion, we especially consider 
the possible explanations of the correlation between fibrinogen attachment to cells and the 
influence of cells on fibrin formation. 
 
In our previous work, the heterogeneous structure in Figure 3-4(b,c) has been linked to the 
higher stiffness (G') in Figure 3-4(a) via microrheology. Thus, the stationary phase S.epidermidis 
cells generate a heterogeneous fibrin structure with higher stiffness while a fibrin forms at the 
presence of the exponential phase S.epidermidis cells has a homogeneous pore size distribution 
like a pure fibrin and with a stiffness no larger than pure fibrin. In Figure 3-5, we demonstrate 
the idea of how strong attraction between cells and fibrinogen could lead to the formation of a 
heterogeneous fibrin network structure. With bacterial cells that strongly attract fibrinogen, the 
originally evenly distributed fibrinogen molecules can have an increased concentration around 
cells, thus, a heterogeneous distribution of fibrinogen, which would finally lead to a 
heterogeneous fibrin network structure. Specially since stationary phase S.epidermidis cells slow 
down the fibrin formation kinetics as described in our previous work (Figure 3-4 and 3-5), the 
described fibrinogen re-distribution process has around 30 minutes to complete (18) which could 
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generate a significant enough heterogeneous fibrinogen distribution leading to a final 
heterogeneous fibrin network structure, therefore, higher fibrin stiffenss.  
 
	
Figure 3-5 | A sketch of the hypothesized mechanism for the noticed phenomena in Figure 
3-4 
When bacterial cells (blue circles) are sticky to fibrinogen (red lines), the attraction between cells 
and fibrinogen may generate a heterogeneous fibrinogen distribution that may result in a final 
heterogeneous fibrin network structure.  
 
Then increase in SdrG expression in the stationary phase S.epidermidis cells could explain the 
stronger interaction between the stationary phase cells and fibrinogen. In the meanwhile, 
bacterial cell can also bind fibrinogen via non-specific binding. Furthermore, in our experimental 
system, fibrinogen is not the only molecule bacterial cells can interact with: thrombin, the 
enzyme that cleaves fibrinogen and initiates the fibrin polymerization, is also positively charged 
and can be attracted to bacterial cell wall. Thus, bacteria-fibrinogen attraction may not be the 
only cause of the fibrin heterogeneous structure. Similarly, bacteria-thrombin attraction could 
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also generate a heterogeneous distribution of thrombin, and therefore, leads to a heterogeneous 
fibrin polymerization. 
 
In conclusion, this study demonstrates the growth phase dependent interaction between 
S.epidermidis fibrinogen and effect of S.epidermidis on fibrin formation, structure and mechanics. 
It contributes to the current understanding of growth phase dependent regulation of S.epidermidis 
virulence factors and the association between bacterial infection and thrombosis. It also shines 
lights on future pharmaceutical solutions to infection-induced thromboembolism.  
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4 Chapter 4: Role of Polysaccharide Intercellular Adhesin in Staphylococcus 
Interaction with Fibrin Network3 
 
4.1 Abstract 
The co-existence of staphylococcal biofilms and host protein clots appears on most, if not all, 
indwelling medical devices, contributing to 50-70% of nosocomial infection – the fifth leading 
cause of death in the US. IcaB, a cell surface-attached protein, has a key role in staphylococcal 
biofilm formation and immune evasion by deacetylating and introducing positive charge to 
polysaccharide intercellular adhesin (PIA) molecules; these charges facilitate adhesion of 
bacterial cells within a biofilm cluster. However, the role of IcaB in staphylococcal biofilm 
formation in the presence of host fibrin network remains unclear. Here we study the role of icaB 
on an in vitro model of biofilm-infected fibrin network. Specifically, using an icaB deletion, we 
evaluated the effects of PIA deacetylation on staphylococcal interaction with a fibrin network 
and the resulting structural and mechanical changes to the network. We find that the ∆𝑖𝑐𝑎𝐵 
mutant degrades fibrin networks faster than the wild-type, both structurally and mechanically. 
Indeed, the ∆𝑖𝑐𝑎𝐵 produce more sspA, a protease that putatively degrades fibrin. We further 
demonstrate that the ∆𝑖𝑐𝑎𝐵 cells, which are more mobile and diffusive than the wild type cells, 
co-localize with the fibrin fibers. This co-localization is correlated with fibrin network 
degradation. These results suggest a pivotal role for icaB in modulating staphylococcal bacterial-
																																																						
3	The work of Chapter 4 is in preparation of publication as “Role of Polysaccharide Intercellular Adhesin 
in Staphylococcal Interaction with Fibrin Network” by Tianhui Ma, J. Scott VanEpps, and Michael 
Solomon
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fibrin interactions and resulting fibrin mechanical structure. This dynamic could be relevant to a 
potential molecular mechanism for infection-induced thromboembolism.   
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4.2 Introduction 
Polysaccharide intercellular adhesin (PIA), first discovered by Mack, D. et.al., is a homopolymer 
of 𝛽-1,6-linked N-acetylglucosamine (GlcNAc) residues1. It dominates the extracellular 
polymeric substance (EPS) microstructure of Staphylococcus epidermidis2,the leading cause of 
device-related infections3. The production of PIA is encoded by the ica gene locus, which 
consists of the icaA, icaB, icaC, and icaD genes, first discovered by Heilmann et al. in S. 
epidermidis 4 but is also present in Staphylococcus aureus5. IcaA and IcaD form a GlcNA-
transferase located in the cellular membrane6 and produce a chain from activated GlcNAc 
monomers7. IcaC elongates the chain to longer polymers and might be involved in the export of 
PIA6. IcaB, located on the cell surface, deacetylates the GlcNAc moieties and thus, introduces 
positive charges on the PIA polymer chain8. This deacetylation step is essential for the surface 
localization of PIA and its intercellular adhesion function. The absence of IcaB impairs the key 
bacterial virulence factor – biofilm formation – and their resistance to immune systems8, 9.  
 
On implanted medical devices, bacteria often appear simultaneously with fibrin 10 11 12 – the 
main structural component of blood clots13, 14. The co-existence of bacteria and fibrin has been 
explained with their bidirectional relationship: bacteria activate inflammation and host clots 
promote bacterial adhesion10. Although the deacetylation of PIA by IcaB has been shown to be 
key to biofilm formation in the absence of host fibrin, it is unclear how it mediates bacterial 
behavior in the presence of fibrin network. IcaB directly controls whether PIA persists on 
bacterial cell walls and thereby influences cell surface properties; these surface properties in turn 
play an important role in cell-fibrin interaction. These interactions may vary the 
microenvironment of the bacterial cells, which may indirectly influence the expression of other 
genes as a response to the environmental change15 and further influence bacterial interaction with 
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fibrin. For example, S.epidermidis has a gene – sspA – that produces glutamyl endopeptidase and 
serine protease that putatively degrades fibrin16 9, which may have a significant effect on fibrin 
integrity. 
 
Fibrin network integrity, defined by its structure and mechanical properties, predict the 
probability of embolism17 18 19. Clinically, device-related infection has been correlated with 
thromboembolism20 21 22. Our previous work suggests that a fibrin network infected with bacteria 
is more prone to rupture than a sterile fibrin network17. Investigation into how icaB influences 
the integrity of a bacteria-infected fibrin network could contribute to molecular understanding of 
the relationship between bacterial infection and thromboembolism.  
 
Here we compare an icaB deletion mutation of S.epidermidis with the wild type (WT) and a 
complement strain with a plasmid containing the icaB gene to study the role of icaB in the 
bacteria-fibrin interaction and the resulting changes to the integrity of a fibrin network. We show 
that the ∆𝑖𝑐𝑎𝐵 degrades the fibrin network faster than the WT. The fibrin degradation is likely 
mediated by increased expression of sspA. We further find that the ∆𝑖𝑐𝑎𝐵 co-localizes with 
fibrin fibers while the WT remains in cell clusters independent of the fibrin fibers.  This 
localization may further facilitate fibrin proteolysis.  
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4.3 Materials and Methods 
 
4.3.1 Bacterial strains 
The clinical isolate S.epidermidis 1457 and its ∆𝑖𝑐𝑎𝐵, together with a complement strain with a 
plasmid containing the icaB gene under a xylose promoter— ∆𝑖𝑐𝑎𝐵 + pTXicaB, were obtained 
from Dr. Michael Otto 8. Briefly, the ∆𝑖𝑐𝑎𝐵 strain is an isogenic 𝑖𝑐𝑎𝐵 deletion (see ref [8]for 
details). To generate plasmid pTXicaB, the icaB gene was amplified using mutagenizing primers 
and cloned into plasmid pTX15 8 23, which was transformed into the ∆𝑖𝑐𝑎𝐵 yielding ∆𝑖𝑐𝑎𝐵 + 
pTXicaB 8. 
 
4.3.2 Bacterial culture conditions and fibrin network formation 
Citrate-free thrombin from human plasma (605206-100U) and plasminogen-depleted 
fibrinogen (Fg) from human plasma (341578-500MG) were purchased from EMD Millipore 
(Billerica, MA).  
 
For culturing S. epidermidis 1457 and the ∆𝑖𝑐𝑎𝐵, a colony from trypic soy agar is inoculated and 
cultured in trypic soy broth with 1 wt.% glucose (TSBG). For ∆𝑖𝑐𝑎𝐵 + pTXicaB, 10𝑢𝑔/𝑚𝑙 
tetracycline (with Hydrochloride, Millipore Sigma) was added to both the agar and broth and the 
1 wt.% glucose was replaced with 1 wt.% xylose (Sigma-Aldrich) (TSBX). After the bacterial 
culture reached exponential growth phase, an INCYTO C-Chip Disposable Hemocytometer 
(Thermo Fisher Scientific) is used to determine the cell concentration. A target number of cells 
are diluted in a 0.5mg/ml Fg solution of 200µl to achieve 200	𝑐𝑒𝑙𝑙𝑠/𝜇𝑙. With this cell 
concentration, a blood clot (or, thrombus) with a size of 0.1 mm3 would have around 20 cells/clot, 
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which could be considered as an initial stage of an infected clot. Fg solutions were made by 
diluting the stock solution with TSBG for S. epidermidis 1457 and the ∆𝑖𝑐𝑎𝐵, and TSBx with 
tetracycline for ∆𝑖𝑐𝑎𝐵 + pTXicaB. TSBG was used for constitution of Fg solutions for sterile 
fibrin networks. Then the samples were transferred to a Nunc Lab-Tek II chambered cover glass 
dish (Thermo Fisher Scientific) kept at 37℃. Fibrin network was initiated by adding thrombin 
(0.5 U/mL as final concentration) to the Fg solution at 37℃. After 15 minutes, 200µl TSBG or 
TSBx was added on top of the fibrin network. The chambered cover glass was sealed with 
Breathe-Easy® sealing membrane (Sigma-Aldrich) to prevent desiccation. The samples were 
held in a 37℃ incubator for the targeted amount of time before analysis, as described below. For 
conditions in which bacteria grew in medium without fibrin, 400µl medium was used instead. 
For ∆𝑖𝑐𝑎𝐵 + pTXicaB growing both with and without fibrin, 10ug/ml tetracycline and 1% xylose 
was added to the medium again after 9-10 hours after the start of the culture to maintain icaB 
expression.  
 
4.3.3 Structure visualization and particle tracking 
Fibrin microstructure, fibrin elasticity, and bacterial cell mobility were evaluated using confocal 
laser scanning microscopy (CLSM), multiple particle tracking, and microrheology as previously 
described by Ma et.al. 17. Briefly, a Nikon A1Rsi CLSM with a 100×, 1.45 NA, oil immersion 
objective (Nikon, Melville, NY) was used. Image volumes for microstructure visualization and 
analysis were obtained by axially scanning from the coverslip to 20 µm above the coverslip in 
increments of 1 µm. The image size was 127.45 × 127.45 µm2 at 512 × 512-pixel resolution. For 
multiple-particle tracking, 2D time series of 500 images with size 42.48 × 42.48 µm2 (512 × 512 
pixels) were collected at 30 frames per second at a distance of 10 ± 5	µm above coverslip. Both 
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image volumes and time series were captured randomly over the specimen dish. Image volumes 
at five different regions in each sample were taken for structure visualization; time series at five 
different regions in each sample were taken for fibrin mechanics. Image projections and 
renderings of the 3D volumes were made with the software ImageJ (http://rsbweb.nih.gov/ij/). 
 
Fibrin was visualized using AlexaFluor 546 (558/573 nm) conjugated human Fg (Thermo Fisher 
Scientific), which was mixed with unlabeled fibrinogen in a molar ratio of 1:4 17. Bacterial cells 
were stained for 30 min with 20 µM SYTO 40 (420/441) (Thermo Fisher Scientific) and PIA was 
stained with 10 µg/mL Wheat Germ Agglutinin, Alexa Fluor™ 488 Conjugate (Thermo Fisher 
Scientific). Sulfate modified Microspheres, diameter 1.0 µm, with yellow-green fluorescent 
FluoSpheres (505/515), 2% solids (Thermo Fisher Scientific) were used for particle tracking 
microrheology. Bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, MO) was adsorbed to 
the microsphere surface to control the interaction between probes and Fg 17 24. BSA was 
dissolved in filtered deionizing water. The probes (0.1% solids as the final concentration) were 
incubated with 0.02 wt % BSA solutions on a roller at room temperature overnight. Probes were 
washed with deionizing water and resuspended into Fg or bacterial/Fg solution before clotting 
with 0.04% solids.  
 
4.3.4 Structure quantification 
The degree of bacteria-fibrin co-localization was calculated from binary images as described in 
17. We define bacteria and fibrin as being co-localized when their fluorescence emission overlaps 
in the same pixel. Briefly, bacteria-fibrin overlap pixels are the intersection of the on-pixels in 
the bacteria and fiber channels, with on-pixels define through a threshold operation. The overlap 
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percentage of every image with respect to fibrin and bacteria was computed by dividing the 
overlap area by the fibrin area and bacteria area, respectively. Image analysis was performed in 
MATLAB R2014b (The MathWorks, Natick, MA).  
 
In the fibrin structure images, fibrin appears to be either branched patterns or patchy patterns. 
We introduce patch percentage to represent the area fraction of the patchy pattern relative to all 
fibrin patterns, including branched and patchy ones, in a certain image. Patch percentages were 
calculated from binary images and the analysis was performed in Python 3.6.4. We first divided 
all of the identified fibrin pixels into contiguous objects by means of cluster analysis. The 
minimal rectangle that encompasses all pixels in a connected object was drawn and the area 
fraction of the fibrin pixel inside this rectangular box was calculated. For example, an area 
fraction that equals 0.36 means that 36% of the box are fibrin pixels with the rest of the pixels 
being voids. A continuous object that is patchy pattern would have a high area fraction whereas 
an object of a branched pattern would have a low area fraction. Thus, we use the area fraction to 
identify whether a fibrin pattern is patchy or branched. As shown in Figure 4-1, an area fraction 
equals 0.36 was chosen to define patches versus branches: if the density is below 0.36, then we 
define the object as a branch, otherwise, the object is defined as a patchy pattern. Figure 4-1 
shows that a non-degraded fibrin image calculated this way has a patch percentage of 16% and a 
fully degraded fibrin image example has a patch percentage of 93%. The patch percentage of 
every image is then calculated by separating fibrin patterns into patches and branches. Using this 
method, we quantified the structural characteristic of a fibrin image. 
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Figure 4-1 Image Analysis of patch versus branch of a fibrin network 
(a) Top row: binary images of a non-degraded fibrin (left), a partially degraded fibrin (middle) 
and a fully degraded fibrin (right). Bottom row: analyzed images of the corresponding binary 
images with yellow indicating branches and blue indicating patches. (b) The result of fibrin patch 
percentage varying with the chosen density value of fiber pixels inside a rectangular box drawn 
around the furthest fibrin pixels in a connected object (c.f. Methods). It shows that the results are 
relatively insensitive to the chosen density. With a chosen density value of 0.36, a non-degraded 
fibrin has a patch percentage of 16% and fully degraded fibrin has a patch percentage of 93%.  
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4.3.5 Microrheology 
The theory and method for using particle tracking microrheology for probing fibrin mechanics 
was described in 17, as adapted from the theory and methods that are well-developed for 
polymers25, 26.  Briefly, we quantify the mean square displacement (MSD) (Δx2(t)) —the average 
squared distance a probe travels in a given lag time – of probes dispersed in the fibrin matrix 
from time series of 2D images. MSDs were computed from probes’ centroids as identified by 
TrackPy 3.0 (http://soft-matter.github.io/trackpy/stable/).  
 
4.3.6 Cell mobility 
Cell mobility in cultures without fibrin was characterized to study the ability of a bacterial cell to 
undergo displacement by means of Brownian motion. Bacteria were cultured without fibrin for 
the measurements cell mobility due to the limitations of experimental methods. Nevertheless, 
they are intrinsic cell properties that would influence the bacterial behaviors at the presence of 
fibrin. A bacterial cell’s mobility is constrained by other bacterial cells, which influences 
whether it has the potential to wander around and find fibrin fibers. It is therefore studied in cell 
cultures without fibrin. It cannot be characterized inside fibrin because once a mobile cell is 
trapped by fibrin, it becomes stagnant10. Bacterial cells were tracked and analyzed by TrackPy 
3.0 and the mobility reported as a diffusivity. Time-series at three different regions were taken 
within each sample for the cell mobility studies.  
 
4.3.7 Zeta potential measurement 
Just like cell mobility measurement, bacteria were cultured without fibrin for the measurements 
of zeta potential due to the limitations of experimental methods. The measurement of zeta 
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potential is not feasible with the original setup with bacteria growing in fibrin. Thus, stationary 
phase bacteria were used to resemble the biofilm phenotype10. Bacterial strains were cultured in 
1-2ml medium (TSBG for S.epidermidis 1457 and its ∆𝑖𝑐𝑎𝐵 and TSBx with 10µg/ml 
tetracycline for ∆𝑖𝑐𝑎𝐵 + pTXicaB) to the stationary phase with the optical density at 600nm 
(OD600) = 1.45 ± 0.1. Stationary phase was used here to resemble the biofilm phenotype in the 
rest of the study. Cells were diluted to c.a. 10𝑐𝑒𝑙𝑙𝑠/𝑚𝑙	for zeta potential measurements made 
using a Zetasizer Nano ZSP (Malvern Panalytical).  
 
4.3.8 RNA extraction and RT-PCR 
After 19 ± 1 hours’ incubation at 37℃ in cover glass dishes as described above, samples were 
completely scraped from the wells and centrifuged at 8000 rpm for one minute to pellet the cells. 
After washing with Milli-Q water, cells were resuspended in an NAES buffer (50mM sodium 
acetate buffer, 10mM EDTA and 1% SDS at pH = 5) and vortexed for one minute. Acid-washed 
glass beads (212-300µm, Sigma-Aldrich) of 0.5 grams were used for homogenizing each sample 
in a Bullet Blender Storm 24 (Next Advance) for 30 minutes. Cell lysis was achieved with 500 
µl TRIzol (Sigma-Aldrich) and 100 µl chloroform (Sigma-Aldrich), followed by a three-minute 
vortex. Following this, samples were centrifuged at 12000 rpm for 15 minutes at 4°C. Then the 
samples were resuspended in 600 µl 70% ethanol (Sigma-Aldrich) and vortexed for one minute. 
Samples were then transferred to spin columns from an RNase free Mini Kit (Qiagen) and 
processed per manufacturer’s instructions. RNA quality and integrity were confirmed using UV 
spectrophotometry and Bioanalzer Purified RNA samples were stored at -80°C. 
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For reverse transcription polymerase chain reaction (RT-PCR), QuantiTect sybr green RT-PCR 
(Qiagen) was performed in 25 µl reactions. The reaction mixture contained 12.5 µl RT-PCR 
Master Mix, 0.25 µl RT Mix, 2 µl of RNA sample (30 ng), and 2 µl of each gene 
forward/reverse-primer (F/R-primer, 12.5 µM) and 6.5 µl of RNase-free water. Thermal cycling 
protocol began with 10 minutes reverse transcription at 50°C, followed by an initial activation 
step of 5 minutes at 95°C, denaturation of 10 seconds at 95°C, and combined 
annealing/extension step at 60°C for 30 seconds for a total of 40 cycles. Sequences for forward 
and  reverse primers are CCAATATAGACAACTTTACC and 
GCAACTATAAGTAGCAATAC, respectively. Both of them have an amplicon length of 119 
and GC% of 35%. The Primer Melting Temperature (Tm) for the forward sspA was 55 and that 
of the reverse sspA was 56.  
 
4.3.9 Time points and experimental conditions   
Measurements were conducted at initial, mid-point, and end-point times: the initial time point is 
recorded within one hour after fibrin network initiation; the mid-point time is 19 ± 1 hours after 
fibrin network initiation; the end point time is 30 ± 1 hours after fibrin network initiation, which 
allows the bacteria to generate a significant effect on the fibrin under the experimental conditions. 
The mid-point time is used in some cases to characterize physical and genetic conditions that 
may be causative of end-point time observations. 
 
in Figure 4-5(a,b) for bacterial locations inside a fibrin network and Figure 4-6 for sspA 
expression. In this study, we hypothesize that Figure 4-5 and 4-6 could be the causes for Figure 
4-2 and 4-5 – the results. A mid time point is therefore used because we want to observe the 
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causes before the results. Specifically, for example, the co-localization of ∆𝑖𝑐𝑎𝐵 and fibrin fibers 
cannot be observed any more at the endpoint time when almost all of the fibrin fibers become 
patches.  
 
4.3.10 Statistics 
Statistics were performed using GraphPad Prism (GradphPad Software, Inc., San Diego, CA). 
One-way ANOVA was used for Figure 4-2, 4-4 and 4-6. Student’s t-test was used for Figure 4-7.  
 
 
4.4 Results: 
4.4.1 S. epidermidis ∆𝒊𝒄𝒂𝑩 alters fibrin network morphology to a higher degree 
than WT  
Figure 4-2 reports the microstructure of fibrin networks infected with S. epidermidis 1457 (WT), ∆𝑖𝑐𝑎𝐵	and ∆𝑖𝑐𝑎𝐵 + pTXicaB. The initial fibrin network, inoculated with bacteria at 200cells/µl 
(c.f. Methods), has a porous structure. Thirty hours later the bacteria have grown within the 
fibrin, leading to some loss of the branched pattern, and giving rise to patchy distribution of 
fibrin. In those samples inoculated with WT and the ∆𝑖𝑐𝑎𝐵 + pTXicaB, branches remain 
between the patchy regions, whereas in the fibrin networks infected with ∆𝑖𝑐𝑎𝐵, the branched 
network pattern is almost completely lost, leaving just dense patches.  
 
To better quantify this observation, we used image analysis to characterize the percentage of 
patchy morphology versus branched morphology (c.f. Methods & Figure 4-1). As shown in 
Figure 4-2b, a fibrin network without bacteria at one hour analyzed in this way has an average 
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patchy pattern percentage of 16 ± 5 %. No difference in fibrin network morphology is noticed 
at one hour: the patch percentage of a sterile fibrin network, a fibrin network infected with the 
wild type, ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + pTXicaB is measured to be 16 ± 7 %, 16 ± 1 %, 17 ± 6 %, 17 ± 2 %, respectively. At the endpoint time, a sterile fibrin network has a patch percentage of 15 ± 5 %, whereas that of a fibrin network infected with the wild type, ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + 
pTXicaB is measured to be 36 ± 10 %, 93 ± 5 % and 46 ± 14 %, respectively.    
 
Hypothesis testing with ANOVA indicates that the patch percentage of a fibrin infected with the ∆𝑖𝑐𝑎𝐵 at the endpoint time are significantly different than the other conditions (P<0.0001). Both 
the wild type and the ∆𝑖𝑐𝑎𝐵-complement strain (∆𝑖𝑐𝑎𝐵 + pTXicaB) have a significant increase 
in patch percentage as compared to their beginning stages (P<0.005) (c.f. Methods). Thus, 
judging from the patch percentage in the fibrin structures, we conclude that the clinical strain 
S.epidermidis 1457 can change the morphology of fibrin networks over time and the change is 
enhanced when infected by ∆𝑖𝑐𝑎𝐵. This change of fibrin morphology from branchy patterns to 
patchy patterns resembles the degradation of fibrin by plasmin (Figure 4-3). The result therefore 
indicates the degradation of fibrin by the bacteria. 
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Figure 4-2 Structural characterization of fibrin degradation 
(a) Images of confocal microscopy of wild-type (WT), ∆𝑖𝑐𝑎𝐵	and ∆𝑖𝑐𝑎𝐵 + pTXicaB (from left 
to right). Red indicate fibrin, blue indicates bacteria. Top row: within one hour after fibrin 
network initiation; Second row:  30 hours after fibrin network initiation; Third row: Zoomed-in 
images from regions in the second row. (b) Patch percentage of sterile fibrin, wild-type (WT), ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + pTXicaB at time zero and 30h. Error bars indicate standard deviation of five 
replicates. An asterix indicates statistical significance.  
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Figure 4-3 Compare fibrin infected with the mutant and fibrin degraded by plasmin. 
Fibrin infected with 100cells/ml at (a) time 0 and (b) 50 hours later when cells grow into 
biofilms; Fibrin with 3.3×10-2U/ml plasmin solution loaded on top at (c) time 0 and (d) 9 hours 
later; pure fibrin at (e) time 0 and (f) time 50h. Scale bar = 10 µm. 
d	
a	 c	
b	
e	
f	
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4.4.2 Fibrin networks infected with the ∆𝒊𝒄𝒂𝑩 becomes a mechanically weaker 
network 
	
Figure 4-4 |  Mean square displacements of probes trapped on fibrin fibers of pure fibrin 
and fibrin infected with the wild-type (WT) S.epidermidis 1457, its ∆𝒊𝒄𝒂𝑩 and the 
complement strain ∆𝒊𝒄𝒂𝑩 + pTXicaB at the starting and ending time point after clot 
initiation, respectively, together with free loating probes in fibrin (Fn) voids and noise floor 
(Fn time 0, WT time 0, ∆𝑖𝑐𝑎𝐵 time 0, ∆𝑖𝑐𝑎𝐵 + pTXicaB time 0 and Fn time end overlap; WT 
time end and ∆𝑖𝑐𝑎𝐵 + pTXicaB time end overlap). Error bars indicate standard deviation of five 
replicates. The probes (0.1% solids as the final concentration) were incubated with 0.02 wt % 
(for probes trapped on fibrin fibers) and 10 wt.% (for probes freely floating in fibrin voids) BSA 
solutions on a roller at room temperature overnight (c.f. Methods). 
 
We hypothesize that the change from branched to patch structure of a fibrin network is a 
consequence of fibrin degradation. Am implication of such a hypothesis is that the fibrin network 
would be less elastic and more viscous.  To test this hypothesis, we applied microrheology (c.f. 
Methods). In Figure 4-4, the mean square displacement (MSD) of submicron particle probes 
trapped onto fibrin fibers reveals the mechanical properties of the fibers. Thus, an ensemble 
average of the MSDs of probes over an entire fibrin clot reveals the mechanical properties of the 
fibrin clot 1. A complete fibrin clot at the experimental concentration is pure elastic, or solid-like 
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1. For a pure elastic solid, the MSD remains fixed over the lag time, i.e. probes tend to fluctuate 
around the same position. When in a purely viscous liquid, the MSD increases linearly with the 
lag time, i.e. probes in a pure liquid undergo Brownian motion over time. Therefore, the log 
slope of the measured MSD, 𝛼, characterizes the viscoelasticity of the material (c.f. Methods). 
For a pure elastic solid 𝛼 = 0 whereas for a pure viscous liquid 𝛼 = 1; for viscoelastic materials 0 
< α < 1, which increasing α indicating more viscous and less elastic character. In Figure 4-4, 
fibrin and infected fibrin at t=1h behave like a pure elastic solid; at the ending time point, fibrin 
infected with the wild type and ∆𝑖𝑐𝑎𝐵 + pTXicaB still behaves like a solid whereas fibrin 
infected with the ∆𝑖𝑐𝑎𝐵 behaves like a viscoelastic material. Fibrin void behaves like a pure 
liquid. 
 
In Figure 4-5a, we show that at the initial stage, sterile fibrin control and fibrin networks infected 
with 200𝑐𝑒𝑙𝑙𝑠/𝜇𝑙 bacteria all behave like an elastic solid with an average 𝛼 value of 0.04 ± 0.02. 
At the endpoint time, the sterile fibrin control, fibrin networks infected with the wild type and ∆𝑖𝑐𝑎𝐵 + pTXicaB remain solid-like with an 𝛼 value of 0.04 ± 0.01, 0.05 ± 0.01 and 0.06 ±0.01, respectively. However, the fibrin network infected with the ∆𝑖𝑐𝑎𝐵 shows 𝛼 = 0.5 ± 0.2, 
indicating that this material has an even balance of elastic and viscous properties. Statistics 
indicate that ∆𝑖𝑐𝑎𝐵 at the endpoint time is significantly different than the rest of the conditions 
(P<0.0001). Thus, a fibrin network infected with the ∆𝑖𝑐𝑎𝐵 changes from an elastic solid to a 
viscoelastic material over time during the replication of the bacterial cells, whereas a fibrin 
network infected with the wild type and the ∆𝑖𝑐𝑎𝐵 + pTXicaB stays elastic till the endpoint time. 
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From the MSDs, we characterized the creep compliance, 𝐽(𝑡), of the fibrin networks. The creep 
compliance J(t) is related to the MSD as the following 2: 
J t = 		 𝜋𝑎 Δ𝑥@(𝑡)𝑘W𝑇  
The creep compliance is the amount of strain a material experiences when a unit stress is applied 
to it.  Generally, the greater the value of J(t), the less rigid the material. Figure 4-5b shows the 
creep compliance, 𝐽 𝑡 	𝑎𝑡	𝑡 = 1𝑠, of fibrin networks at different conditions. We show that at the 
initial stage, sterile fibrin and infected fibrin have an average 𝐽(𝑡 = 1𝑠) value of 1.2 ±0.25	𝑃𝑎8. At the endpoint time, the sterile fibrin control, fibrin networks infected with the wild 
type and ∆𝑖𝑐𝑎𝐵 + pTXicaB marinating comparable rigidity with 𝐽(𝑡 = 1𝑠) values of 1.10 ±0.26	𝑃𝑎8, 0.42 ± 0.12	𝑃𝑎8 and 0.52 ± 0.15	𝑃𝑎8, respectively.  However, the fibrin network 
infected with the ∆𝑖𝑐𝑎𝐵 has  𝐽(𝑡 = 1𝑠) = 10.5 ± 5.7	𝑃𝑎8.  This order of magnitude increase in 
compliance indicates that the material is significantly less rigid at the endpoint time relative to 
the initial time (p<0.0005).  Fibrin infected with the wild type at the starting and the endpoint 
time do not differ significantly from each other; neither does fibrin infected with ∆𝑖𝑐𝑎𝐵 + 
pTXicaB differ from X (P>0.99) (c.f. Methods). Judging from Figure 4-5(a) and 4-5a(b), a fibrin 
network infected with ∆𝑖𝑐𝑎𝐵 becomes mechanically weaker over time, whereas a fibrin network 
infected with the wild type and the ∆𝑖𝑐𝑎𝐵 + pTXicaB strain does not display a significant 
mechanical change. Thus, fibrin network morphologic changes caused by presence of wild type 
and ∆𝑖𝑐𝑎𝐵 + pTXicaB do not lead to significant change in mechanical properties, whereas ∆𝑖𝑐𝑎𝐵 does. Potential explanations are provided in the discussion section.  
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Thus, the significant morphologic changes of fibrin – from branches to patches – caused by ∆𝑖𝑐𝑎𝐵 is associated with significant change in fibrin mechanics, as the fibrin becomes more 
liquid-like and less rigid.  
	
Figure 4-5 | Mechanical characterization of infected fibrin networks by microrheology 
 (a) The log slope of the MSD curves,	𝛼, of probes trapped on fibrin networks at t =1h and t = 
30h (b) Creep compliance J(t) at t=1s of sterile fibrin, wild-type (WT), ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + 
pTXicaB at one hour and 30 hours after fibrin network initiation. Error bars indicate standard 
deviation of five replicates in both (a) and (b). Asterix indicates statistical significance. 
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4.4.3 ∆𝒊𝒄𝒂𝑩 co-localizes with fibrin network 
Figure 4-5 reports the degree of co-localization of bacterial cells and fibrin. As shown in Figure 
4-5a, the bacterial cells of the wild type and the ∆𝑖𝑐𝑎𝐵-complement strain (∆𝑖𝑐𝑎𝐵 + pTXicaB) 
persist as clusters; in these materials, the fibrin fibers are exposed, whereas the cells of the ∆𝑖𝑐𝑎𝐵 
co-localize with the fibrin. The zoomed-in images show the location of PIA relative to bacterial 
cells. PIA appears to be concentrated inside the cell clusters of the wild type and ∆𝑖𝑐𝑎𝐵 + 
pTXicaB.  On the other hand, PIA is around every ∆𝑖𝑐𝑎𝐵 cell.  
 
Figure 4-5b quantifies the degree of bacteria-fibrin co-localization. At mid time point, 7.7 ±5.8 %, 63 ± 13 % and 19 ± 5.9 % of the fibrin area is co-localized with the wild type, the ∆𝑖𝑐𝑎𝐵 and the ∆𝑖𝑐𝑎𝐵 + pTXicaB strains, respectively; and the bacteria-fibrin co-localization is 7.6 ± 3.8 %, 37 ± 6.0 % and 15 ± 4.1 % of the bacteria area of wild type, the ∆𝑖𝑐𝑎𝐵 and 
the ∆𝑖𝑐𝑎𝐵 + pTXicaB strain, respectively. In both cases, the ∆𝑖𝑐𝑎𝐵-fibrin overlap ratio at the 
mid time point is significantly different than the rest of the conditions (P<0.0001) (c.f. Methods). 
Thus, when growing in fibrin, the ∆𝑖𝑐𝑎𝐵 tends to cluster on the fibrin network whereas the wild 
type and ∆𝑖𝑐𝑎𝐵 + pTXicaB tend to cluster independently of the fibrin network.  
 
We hypothesized that the difference in the cell location relative to the fibrin network could result 
from differences in cell surface charge and cell mobility of the wild type and the ∆𝑖𝑐𝑎𝐵. In 
Figure 4-5c, we show that the zeta potential of the stationary-phase wild type, ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + pTXicaB (c.f. Methods) are −6.8 ± 1.6 𝑚𝑉, −22.4 ± 2.2 𝑚𝑉 and (−13.5 ±4.7)𝑚𝑉, respectively, with ∆𝑖𝑐𝑎𝐵 being significantly different than the wild type (P<0.0001) 
and the ∆𝑖𝑐𝑎𝐵 + pTXicaB strain (P<0.05). Thus, the ∆𝑖𝑐𝑎𝐵 is more negatively charged.  
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Cell mobility was meausred to characterize the ability of a bacterial cell to explore its local 
environment through diffusion (c.f. Methods). A free-floating (planktonic cell) will have a higher 
mobility than a cell trapped in an aggregate or biofilm. The dynamics of the former will be 
diffusive, whereas the dynamics of the latter will be localized.  In Figure 4-5d, we report the 
mean squared displacement (MSD) of cells in media at t=1s, as measured by particle tracking 
microscopy (c.f. Methods). The values of MSD at t=1s of the wild type, ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + 
pTXicaB are (0.005 ± 0.0008)𝜇𝑚@, (0.06 ± 0.02)𝜇𝑚@ and (0.008 ± 0.0009)𝜇𝑚@, 
respectively. Statistics indicates that the MSD at 1s of ∆𝑖𝑐𝑎𝐵 is significantly different than the 
wild type and ∆𝑖𝑐𝑎𝐵 + pTXicaB (P<0.01). In Figure 4-6, we furthermore show that the slope of 
the ∆𝑖𝑐𝑎𝐵 MSD curve is positive while that of the wild type and ∆𝑖𝑐𝑎𝐵 + pTXicaB are nearly 
zero. It shows ∆𝑖𝑐𝑎𝐵 cells are free and diffusive whereas the wild type and ∆𝑖𝑐𝑎𝐵 + pTXicaB 
are trapped and immobile.  
 
	
Figure 4-6 | Mean square displacements of bacterial cells of wild-type (WT), ∆𝒊𝒄𝒂𝑩 and ∆𝒊𝒄𝒂𝑩 + pTXicaB at the mid time point. Error bars indicate standard deviation of five 
replicates. 
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Figure 4-7 | Bacterial localization relative to fibrin fibers 
 (a) Confocal microscopy singles stacks of fibrin infected with wild-type (left), ∆𝑖𝑐𝑎𝐵 (middle) 
and ∆𝑖𝑐𝑎𝐵 + pTXicaB (right) at the mid time point after fibrin network initiation. Red indicates 
fibrin, blue indicates bacteria and green indicates PIA. The top row shows the zoomed-in images 
of regions in the large image and the corresponding channel with only PIA on the right. (b) 
Fibrin-bacteria overlap ratio as compared to whole fibrin area (left) and whole bacterial area 
(right). Error bars indicate standard deviation of five replicates. (c) Zeta potential of stationary 
phase wild-type (WT), ∆𝑖𝑐𝑎𝐵	and ∆𝑖𝑐𝑎𝐵 + pTXicaB. Error bars indicate standard deviation of 
eight replicates. (d) Mean square displacements at t=1s of bacterial cells of wild-type (WT), ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + pTXicaB. Error bars indicate standard deviation of three replicates. Asterix 
indicates statistical significance. 
 
 
4.4.4 ∆𝒊𝒄𝒂𝑩 has an increased sspA expression in fibrin 
Figure 4-8 reports the sspA expression of the wild type, ∆𝑖𝑐𝑎𝐵 and ∆𝑖𝑐𝑎𝐵 + pTXicaB growing 
with and without fibrin. At the mid time point, there is no difference in the wild type sspA 
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expression growing with and without fibrin, with the fold increase (with fibrin versus without 
fibrin) being 1.3 ± 0.9. No significant change is noticed in the sspA expression of the ∆𝑖𝑐𝑎𝐵 and 
the wild type when both grow without fibrin, with the fold increase (∆𝑖𝑐𝑎𝐵 versus the wild type) 
being 0.9 ± 0.4. the fold increase of ∆𝑖𝑐𝑎𝐵 versus wild type growing in fibrin is 2.3 ± 1.1. The 
fold increase of ∆𝑖𝑐𝑎𝐵 growing with versus without fibrin is 3.4 ± 1.9. Statistics indicate that 
both are significantly above 1 (P<0.05).  
 
Meanwhile, none of the conditions displays a significant increase in sspA expression when the 
wild type is compared to ∆𝑖𝑐𝑎𝐵 + pTXicaB, as shown in Figure 4-8b. The fold increase of wild 
type growing with versus without fibrin, ∆𝑖𝑐𝑎𝐵 + pTXicaB versus wild type growing without 
fibrin, ∆𝑖𝑐𝑎𝐵 + pTXicaB versus wild type growing with fibrin and ∆𝑖𝑐𝑎𝐵 + pTXicaB growing 
with fibrin versus without fibrin are 1.2 ± 0.7, 1.4 ± 0.8, 1.1 ± 0.4 and 1.1 ± 0.5, respectively. 
Thus, ∆𝑖𝑐𝑎𝐵 has an increased sspA expression in fibrin both compared to ∆𝑖𝑐𝑎𝐵 growing 
without fibrin and compared to wild type growing in fibrin.  
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Figure 4-8 | Comparison of sspA expression under different conditions 
 (a) Fold increase of sspA expression of wild-type (WT) and the ∆𝑖𝑐𝑎𝐵 growing with and without 
fibrin at the mid time point. WT = wild-type; WT.Fn = wild type in fibrin; ∆𝑖𝑐𝑎𝐵.Fn = ∆𝑖𝑐𝑎𝐵 in 
fibrin. For example, WT.Fn/WT means the fold increase of the wild type sspA expression 
growing with fibrin versus growing without fibrin. (b) Fold increase of sspA expression of wild-
type and ∆𝑖𝑐𝑎𝐵 + pTXicaB in biofilms and in fibrin. Comp = ∆𝑖𝑐𝑎𝐵 + pTXicaB; Comp.Fn = ∆𝑖𝑐𝑎𝐵 + pTXicaB in fibrin. Statistics indicates none of the compared fold increases are 
significantly above 1 (P<0.05). Error bars indicate standard deviation of seven replicates in both 
(a) and (b). Asterix indicates statistical significance. RNA samples were partially extracted by 
Janice Sim. 
 
 
4.5 Discussion: 
This study compares an S. epidermidis ∆𝑖𝑐𝑎𝐵 with the wild type to investigate how the 
deacetylation and the introduction of positive charges to PIA molecules by IcaB influences 
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bacterial interaction with a fibrin network. We find that without IcaB, the bacteria co-localize 
onto the fibrin network, express more sspA, and degrade fibrin to a higher degree both 
structurally and mechanically relative to wild type. Here we consider potential explanations of 
the observations and discussion implications for staphylococcal behaviors and human disease. 
 
We speculate that the capacity of bacteria to co-localize onto strands of the fibrin network is a 
key contributor in the cell’s capacity to induce structural degradation of fibrin network into 
patches. In Figure 4-2, we show that at the endpoint time, an entire fibrin network infected with ∆𝑖𝑐𝑎𝐵 has almost been degraded into patches whereas a great portion of a fibrin infected with 
the wild type are still branches. In Figure 4-9, we show the images of bacteria together with 
fibrin at the endpoint time. For the wild type and ∆𝑖𝑐𝑎𝐵 + pTXicaB, we see that the fibrin 
branch-region is bacteria-free and the fibrin patchy-region overlaps with the bacterial patches. 
The ∆𝑖𝑐𝑎𝐵, on the other hand, grow on the fibrin fibers much earlier (at least no later than the 
mid time point as shown in Figure 4-7) and that could be the reason of why ∆𝑖𝑐𝑎𝐵 degrades a 
fibrin faster. At the endpoint time, both the fibrin patches and the ∆𝑖𝑐𝑎𝐵 cells are evenly 
distributed as shown in Figure 4-9. 
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Figure 4-9 | Single stacks of confocal microscopy of wild-type, DicaB and DicaB (pTXicaB) 
(from left to right) at the ending time point after clot initiation. Red indicate fibrin, blue 
indicates bacteria. 
Structurally, at the endpoint time, we observe changes from branched pattern to patchy pattern in 
the morphology of fibrin infected with both wild type and ∆𝑖𝑐𝑎𝐵. Mechanically, however, only 
the fibrin network infected with ∆𝑖𝑐𝑎𝐵 has a significant change as shown in Figure 4-5. The 
images in Figure 4-9 indicates that the wild type bacteria degrade the co-localized fibrin and 
incorporate themselves – a biofilm cluster – into the fibrin network. The wild type MSD values 
reported in Figure 4-7d and its MSD curve in Figure 4-7, which agrees with that measured by 
Stewart.et.al.27, shows that a wild type cluster is an elastic solid with every cell being restricted 
by the biofilm they form. Therefore, the fibrin structurally degraded by the wild type still 
remains as a connected network behaving like a solid. The slight drop of the creep compliance 
value may be caused by the addition of mass (biofilm clusters) to the material. On the other hand, 
the fibrin infected with the ∆𝑖𝑐𝑎𝐵 may not be a connected network anymore at the endpoint time 
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because first, the degree of degradation is significantly higher than that of the wild type (Figure 
4-2b) and second, the ∆𝑖𝑐𝑎𝐵 cells are mobile and diffusive – more like planktonic cells with no 
mechanical contribution (Figure 4-7d and Figure 4-6).  
 
From Figure 4-7, we hypothesis that cell surfaces with strong negative charge and diffusive cell 
populations are factors in the co-localization of bacteria and the fibrin network. Fibrin is 
positively charged17. Therefore, a negatively charged cell surface would be attractive to the fibrin 
fibers. In the meanwhile, only a mobile and diffusive cell – the ∆𝑖𝑐𝑎𝐵 – could have the 
opportunity to be attracted to the fibrin. IcaB has been shown to be a significant factor in biofilm 
formation. Without IcaB, PIA may not be able to bind the cells with each other to form a biofilm 
community8. Thus, the ∆𝑖𝑐𝑎𝐵, being both mobile and diffusive, behaves more like a planktonic 
cell. Whereas, a cell in the wild type is constrained in the biofilm clusters and may not have the 
chance to bind onto a fibrin fiber. As a biofilm-former, a newborn cell would be stick onto other 
cells in the cluster9 rather than onto fibrin fibers.  
 
A limitation of the zeta potential measurement is the difference in the experimental conditions. 
The measurements of zeta potential are performed on planktonic stationary-phase cells cultured 
at 200rpm (c.f. Methods). The PIA produced by the ∆𝑖𝑐𝑎𝐵 could be in the solvent as suggested 
by Vuong et.al.8. However, in Figure 4-7a, we see the ∆𝑖𝑐𝑎𝐵 cells are surrounded by PIA. This 
could be due to the no-shaking in the experimental condition. Nevertheless, the PIA molecules 
surround the ∆𝑖𝑐𝑎𝐵 cells without deacetylation are negative, whereas the PIA molecules sticking 
to the wild type cell surfaces have positive charges. Regardlessly, we speculate that the extra 
negative charges on the cell surface may not be a necessity for the co-localization of the ∆𝑖𝑐𝑎𝐵 
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cells and the fibrin fibers – the difference in mobility may be enough to generate the difference 
in cell location relative to fibrin fibers.  
 
We studied a ∆𝑖𝑐𝑎𝐵 complement strain – ∆𝑖𝑐𝑎𝐵 + pTXicaB – to ensure that plasmid expression 
of icaB recovers the effects created by the. Judging from the results of fibrin patch percentage 
(Figure 4-2b), infected fibrin mechanics (Figure 4-5), bacteria-fibrin overlap ratio (Figure 4-7b), 
zeta potential (Figure 4-7c) and cell mobility (Figure 4-7d), the complement strain does not fully 
recover the effect caused by the all the way to wild type, although only the zeta potential of the 
complement strain is significantly different than the wild type (P<0.0005). This consistency may 
further suggest the causality of zeta potential and cell mobility to bacteria-fibrin overlap ratio and 
that of the bacteria-fibrin overlap ratio to fibrin morphologic and mechanical changes. This 
partial recovery may be due to that the culturing condition could not keep all the bacteria 
expressing the plasmid correctly.  
 
This study addressed the role of the IcaB – the deacetylation and the introduction of positive 
charges to the PIA molecules – in bacterial interaction with a fibrin network. The deficiency of 
one surface protein – IcaB – could resolve in changes of bacterial behaviors in host protein 
networks, including their relative location to the host network, cell mobility and gene 
expressions. This further leads to a different influence on the integrity of the host network. Our 
finding that the ∆𝑖𝑐𝑎𝐵 co-localizes with the fibrin fibers and degrades a fibrin significantly faster 
than the wild type would contribute to the current understanding of the co-existence and the 
interaction between bacteria and host protein networks. The bacterial influence on fibrin integrity 
could be related to thromboembolism, which motivates future in vivo studies.  
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5 Chapter 5: Hydrogel materials as rheometer tooling for the transient delivery 
of additives during mechanical rheometry4  
 
5.1 Abstract:  
 
Mechanical rheology is widely applied to study soft matter; however, the transient rheological 
properties of these materials are often sensitive to additives in a way that is difficult to study 
because of the challenge in their delivery in situ. Because it is of interest to study the transient 
rheology of self-assembled soft matter as such additives diffuse into the material and generate 
microstructural and physicochemical changes, we have developed rheometer tooling comprised 
of a porous hydrogel. The tooling allows additives to be dosed through a rheometer plate or cone, 
and the consequent effect of these additives on a material’s mechanical response measured.  The 
disposable hydrogel rheometer plate is synthesized by means of the photopolymerization of an 
aqueous polyethylene glycol (PEG) diacrylate solution. We precisely control the dimensions of 
the rheometer tool and accommodate shrinkage, by fixing the mold to a five-axis optomechanical 
stage, which specifies the pitch, yaw, and translational position of the tool relative to its 
rotational axis. We demonstrate the performance of the tooling by measuring the viscoelastic 
properties of aqueous polyethylene oxide (PEO) solutions and comparing the values to those 
obtained using standard, stainless steel fixtures.  We measure the diffusion of small molecules – 
																																																						
4	The work of Chapter 5 is in preparation of publication as “Hydrogel materials as rheometer tooling for 
the transient delivery of additives during mechanical rheometry” by Tianhui Ma, Megan Szakasits, Peng-
Kai Kao, J. Scott VanEpps, and Michael Solomon	
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NaCl in this case – through the hydrogel material, to confirm its function and characterize the 
time scale over which additives can be delivered.  We apply the hydrogel fixture to dose 
self-assembled soft matter and gels with additives, and thereby demonstrate that the tooling can 
be used to study the kinetics of material property variation due to the diffusion of molecular 
additives into the soft material though the hydrogel plate. Examples materials studied are 
solutions of colloids and proteins, with the additives dosed being salts and enzymes. 
 
5.2 Introduction: 
	
Mechanical rheology is used to study the flow and mechanical properties of complex fluids; the 
effects of additives on the transient rheology of these materials have scientific and technological 
importance. Instances of additive effects on soft matter rheology are common.  For example, the 
transient rheology of colloidal suspensions during gelation is important in many industries 1. 
Other examples in which transient measurements are important include the addition of thickeners, 
gelling agents, and emulsifiers to food products 2, the use of reactive polymeric materials as 
rheology modifiers of lubricating greases in the oil industry 3, and the control over ionic strength 
in micelle solutions to change the flow properties in consumer products 4. Turning to biological 
systems, protein solutions are sensitive to salinity, pH as well as chaotropic and kosmotropic 
agents, etc. There is furthermore interest in studying the transient rheology of protein networks 
formed through enzymatic process.  An example of such a transient process would include blood 
clot fibrinolysis as plasmin diffuses into and dissolves a clot 5 and the interactions between blood 
clots and continuously growing bacterial biofilms6.  The blood clot in this case is principally 
comprised of a fibrin polymer network.  It is produced by means of enzymes (i.e., thrombin) and 
degraded by another enzyme (i.e., plasmin) 7 
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Rheological properties are of course sensitive to other environmental factors such as temperature 
and light, as well as electric and magnetic fields.  Mechanical rheometers are well equipped for 
in situ study of the effects of these factors on rheology through the development of tooling that is 
e.g., transparent, equipped with Peltier or other elements.  On the other hand, current rheological 
methods have limited capabilities to study the transient rheology that results from the dosage of 
molecular additives. Currently, to conduct such measurements, components must be mixed ex 
situ.  The mixture is then loaded onto the rheometer. Potential problems with this technique 
include: difficulty in establishing an initial time point for the additive dosing; uncontrolled 
deformation during the loading of the material – during which time the additive is functional – 
onto the rheometer; loss of the few minutes of data while the specimen is being loaded onto the 
rheometer.  
 
As example, the formation of colloidal gels can be sensitive to the addition of salt 1. In weakly 
aggregated colloidal gels, mixing the sample and loading it onto the rheometer can disrupt the 
gel network, because it is weak. Therefore, it is of interest to study the transient rheology of 
gelation due to salt ion diffusion into the sample under in situ conditions.   
 
As an additional example, consider the fact that the enzyme plasmin dissolves fibrin networks, as 
the primary structural constituent of blood clot.  To observe the transient rheological signature of 
such degradation, the network first must be synthesized under in situ conditions, Three 
components – fibrinogen (the monomers that build the fibrin network), thrombin (the enzyme 
that triggers the fibrin network polymerization) and plasmin – must be mixed together to 
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polymerize fibrinogen into fibrin network. However, this current procedure measures the effect 
plasmin on a forming fibrin network, not how plasmin diffuses in and dissolves a completely 
formed fibrin network, which is a more physiologically relevant scenario 5.  
To address needs of this kind,, in this paper we design, build, and test rheometer tooling that 
allows for the in situ diffusion of additives into specimens during rheological measurement.  The 
availability of such fixtures will improve the scope for rheological characterization of materials 
that are sensitive to the introduction of molecular additives. 
 
Few methods for in situ dosing of additives during rheometry have been previously developed. 
Pavlovsky et al., modified a commercial rheometer into a continuously fed bioreactor that allows 
the study of bacterial biofilm properties under different growth conditions by steady flow of 
media across the extended gap of a parallel-plate rheometer. However, this set-up did not allow 
simultaneous rheometry and additive dosing, because the media flow occurred for gap 
dimensions larger than typical of rheometry8.  
 
Boyer et al., applied a porous plate (hole size = 5mm covered by 200um Nylon mesh) to study 
the rheology of dense particle suspensions. Since liquid can freely flow in and out of the holes, 
sample volume and particle volume fraction can vary during the measurements 9 in response to 
osmotic pressure or normal force differences. This method differs somewhat from the aim here 
of the in situ delivery of molecules to a rheological specimen.  
 
On the other hand, specimens for microrheology, a technique that uses the dynamics of passive 
or active probes to characterize the viscoelasticity of the microenvironment in which the probes 
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are dispersed, can be configured to allow for additive delivery. For example, Schultz et al., 
applied microrheology to study the degradation of hydrogel in response to cell-secreted enzymes 
by tracking the Brownian motion of the embedded probe particles (carboxylated polystyrene 
probes) 10. Similarly, Sato and Breeveld studied the transient rheology of solvent-responsive 
complex fluids via microrheology by introducing and tracking the fluorescent particles in the 
fluids 11. Nevertheless, such measurements have limitations on the macroscopic level. 
 
Another method to configure rheometer tooling is to 3D print the fixtures, as described by 
D.A.Bikos and T.G.Mason, et.al 12. In this work,,tooling comprised of disposable plastic was 
designed and 3D printed to allow volume matching, uniform strain field, higher torque and 
greater control over tooling surface roughness. While this method produces customizable tooling, 
the material selections demonstrated to date does not accommodate in situ delivery of additives 
during rheometry, as addressed in the present work.  
 
Hydrogels are widely used in both scientific and industrial settings 13 14. Their porosity and 
biocompatibility have found applications as tissue scaffolds 13.  At the same time, the stiffness of 
hydrogels is also controllable 14. Hydrogels have been 3D printed to provide materials with 
spatially controlled functionality 15. Because of their specific combinations of porosity and 
rigidity, hydrogels have been used as a solid membrane for the diffusion of additives 16. 
Therefore, hydrogels are an excellent candidate material to create rheometer tooling that is both 
porous – to allow diffusion of additives during measurement – and rigid – to allow mechanical 
rheometry.  
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In this paper, we present the synthesis of a rheometer fixture made of a rigid, porous hydrogel 
that allows for transient delivery of additives during mechanical rheometry. We characterize the 
stiffness of the hydrogel material and its permeability to ionic, molecular, and protein solutions. 
The utility of the hydrogel fixture for rheometry is established by comparing its performance to 
that of commercial, stainless steel, rheometry tooling for the measurement of the rheological 
properties of complex fluids.  We also illustrate two applications of the fixture in which the 
hydrogel tooling is used to study the kinetics of material rheology due to the diffusion of 
molecular additives through the hydrogel plate.   
 
5.3 Materials and Methods: 
5.3.1 Study Design 
Here we present the conceptual design of the hydrogel rheometry tooling for the delivery of 
molecules during the rheological measurements. First, we develop a hydrogel that is both rigid 
and permeable. Second, we present ways to use the hydrogel tooling with commercially 
available rheometers.  We offer two approaches:  one is simple and quick to execute; the other is 
more laborious to implement, but yields tooling alignment that is configured to ~14 micron 
precision. Third, we deploy test solutions to demonstrate 1) the performance of the hydrogel 
tooling as compared to commercial ones; 2) examples of application of the hydrogel tooling to 
address needs for transient rheology of materials in the presence of additives delivered in situ. 
Finally, we present the development of a hydrogel fixture for cone and plate rheometry.  
  
5.3.2 Hydrogel Plate Design and Production 
The hydrogel material for the rheometer tooling is synthesized by photopolymerization of 33.2 
wt. % poly(ethylene glycol) diacrylate (PEGDA) (MW 750), 66.4 wt. % water, and 0.4 wt. % 
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photoinitiator, 2-hydroxy-2-methyl-propiophenone. This aqueous pre-hydrogel solution is mixed 
and rolled overnight. A hydrogel plate is generated by first pouring this aqueous solution into a 
glass ring mold (c.f. Figure 5-1a,b), made from cut glass tubes, placed on either a petri dish or a 
glass slide and then illuminating UV light from beneath for two minutes. Shrinkage appears after 
the solution polymerizes into a hydrogel plate. Hydrogel plates generated by glass ring molds 
with an inner-diameter = 54 mm and 43.5 mm are measured to be 53.0 ± 0.1	mm and 43.0 ±0.1	mm, respectively.  
 
The stiffness of the synthesized hydrogel is measured on a RSA3 Dynamic Mechanical Analyzer 
(TA Instruments). A three-point bending method is used and the converted tensile stress is found 
to be 77 ± 14𝑘𝑃𝑎 (n = 3).  
 
5.3.3 Visually-Aligned Rheometer Tooling 
The following simple procedure was used to produce hydrogel tooling with concentricity 
alignment error of 0.5 ± 0.04	𝑚𝑚 (n=3), as measured in ImageJ. We first used a visual aligning 
method to incorporate the hydrogel plate onto a rheometer for a parallel plate geometry. The 
hydrogel plate is formed around a steel cone tooling (20mm in diameter, 2°) as a spindle to the 
rheometer. As shown in Figure 5-1, we visually align the glass ring with the outer circle on the 
template and the spindle with the inner circle. After alignment, the template is removed, and the 
aqueous pre-hydrogel solution is poured into the glass ring mold to make a hydrogel plate with 
the desired thickness (typically ~ 5 mm). The product together with the glass ring and the bottom 
petri dish is then rinsed with water and the hydrogel tooling is carefully removed from the glass 
ring. We attach the hydrogel plate tooling onto a commercial rheometer, which is easily 
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accomplished because the hydrogel material has been gelled around the standard commercial 
plate. A solvent trap and humidifier is used to keep the hydrogel plate hydrated during the 
tooling setup and the experiments.  
	
Figure 5-1 | Visually-Aligned Hydrogel Tooling 
 (a) A photo taken to show the alignment of the glass ring and the spindle (a commercial cone 
20mm in diameter for rheometry) with a template beneath. (b) A photo to show a hydrogel plate 
after generation. Scale bar = 20 cm. This method was developed together with Megan Szakasits. 
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5.3.4 Mechanically Aligned Rheometry Tooling 
The following procedure was used to produce a hydrogel tooling with concentricity alignment of 
precision 14𝜇𝑚. To generate a hydrogel tooling with precise alignment, five dimensions are 
specified relative to the central rotational spindle of the rheometer, as shown in Figure 5-2a.  
These dimensions are the plate-spindle tilt control – 𝜃, 	∅ to specify the orthoganality of the plate 
relative the spindle – and the x, y, z control to align the center of plate relative to the spindle axis. 
Figure 5-2b shows the procedure to find the center of the ring to locate the spindle. To control 
the five dimensions, we incorporate the tilt control and the z control from a commercial 
rheometer (Figure 5-2c). The spindle used is a steel cone (25mm in diameter, 2°, Anton Paar). 
The spindle is first attached to the rheometer. The configuration of the rheometer itself ensures 
that the spindle stays perpendicular to the bottom stage. A UV light is placed on the bottom stage. 
A glass slide is placed on top of the UV light for the fabrication of the hydrogel plate. In the 
zoomed-in photo in Figure 5-2c, a level is placed on the UV light to show the bottom plate where 
a hydrogel plate will be generated remains flat. Two micrometers that control the x, y dimension 
of the glass ring mold are fixed onto the bottom stage, which is also an optical table. First, we 
roughly locate the glass ring in the middle of the spindle. Then we set zero gap of the spindle 
relative to the bottom glass slide. We then translate the spindle to 0.5mm above the glass slide. 
Applying the method described in Figure 5-2b, we locate the glass ring mold to the center of the 
spindle.  A humidifier and solvent trap are again used to control the humidity. Although the 
hydrogel plates were re-generated for each replicate in this study, the hydrogel tooling can also 
be stored in water for reuse. 
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Figure 5-2 | Mechanically-Aligned Hydrogel Plate Tooling 
 (a) Schematic showing the five dimensions to control for the hydrogel plate production: spatial 
dimensions x, y, z and tilt angles 𝜃	and	∅. (b) Schematic illustrating the procedure to find the 
center of a circle so as to locate the spindle to the center of the glass ring mold. The outer large 
ring indicates the glass ring mold; the inner small rings indicates the spindle. The spindle starts 
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from position 1, where it touches the edge of the glass ring, moving by controlling a micrometer 
along the x axis to position 2, where it touches the ring again. Calculate the position of the 
middle of 1 and 2 and define it as position 3; starting from 3, along the y axis, move the spindle 
to position 4 and then position 5, the middle of 4 and 5 is defined as position 6, which is the 
center of the circle. (c) Photograph of the rheometer tooling.  From top to bottom: z and tilt 
control provided by commercial rheometer, the glass ring mold, micrometer for x,y control. The 
zoomed-in image shows a level confirming that the bottom surface is level. This method was 
developed together with Megan Szakasits and Peng-Kai Kao. 
 
5.3.5 Test solutions 
A 4.0 wt.% polyethylene oxide (PEO) (Mn = 1,000,000) (Polyscience, Inc.) is used to compare 
the accuracy of the hydrogel tooling with standard stainless steel tooling for rheometry. PEO 
powder is dissolved in deionized (DI) water and rolled for three days before use. Gellan gum 
(PhytagelTM, Bioreagent, plant cell culture tested, powder, Sigma-Aldrich) solution (0.75 wt.% 
with 250mM NaCl in deionized (DI) water) is made and used to run transient creep tests.  
 
To demonstrate an application of the hydrogel fixture, a polystyrene colloidal gel is produced. 
The colloidal suspension is 1.5 wt.% carboxylate-modified polystyrene colloids of 1𝜇𝑚  in 
diameter (ThermoFisher Scientific). It is prepared by washing the particles three times in DI 
water (twice at 5000G for 10min and once at 5000G for 15min) and resuspended in a mixture of 
H2O (DI water) and D2O (ThermoFisher Scientific) with a ratio of 3:7, to match the density of 
the particles.  Magnesium chloride (MgCl2) was used to aggregate the polystyrene colloidal 
solutions into gels.  A commercial MgCl2 solution (BioUltra, for molecular biology, Sigma-
Aldrich) is diluted from 2.0M to 80mM, and then added to the colloidal suspension. 
 
In the other application, we measure the rheology of fibrin network degradation via diffusion of 
plasmin. The fibrin network is formed from platelet-poor-plasma. New Zealand White rabbit 
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whole blood was collected into citrate tubes right after euthanasia. Within one hour, whole blood 
samples were centrifuged (3000g, 5min) to yield platelet-poor-plasma. Coagulation was initiated 
by adding calcium chloride (3mM final concentration). Plasmin aliquots were made by 
dissolving the lyophilized human plasmin (Plasmin, EACA- and Lysine-Free, Human Plasma, 
Millipore Sigma) in filtered deionized (DI) water (Milli-Q® Type 1 Ultrapure Water Systems, 
Millipore Sigma). A 0.33U/ml plasmin solution was made by diluting the plasmin aliquots with 
Hanks’ Balanced Salt Solution (HBSS) (1X, without phenol red, with calcium, with magnesium).  
 
5.3.6 Dosage of additive solutions 
The aqueous pre-hydrogel solution in the glass ring mold has a curved surface at the top because 
of how the solution wets the glass ring. This interface yields a shallow bowl on top of the 
hydrogel plate after the photopolymerization. For a hydrogel plate of 53 mm in diameter, the 
maximum volume of liquid this shallow bowl can reliably hold is ~ 2 ml. This depression is used 
as a reservoir to contain additive solutions to be dosed to the specimen. That is, the additive 
solution is spread evenly on top of the hydrogel plate in the shallow bowl to initiate additive 
delivery through the hydrogel plate below in the application examples. For the corresponding 
control experiments, the reservoir is filled with DI water. 
 
Hydrogel is synthesized with the same composition has been proven to be permeable; it has been 
used as a membrane in literature 16. We conducted an experiment to measure the rate of MgCl2 
diffusion through a hydrogel plate 4mm in thickness. The hydrogel plate is supported in a 400ml 
glass beaker, which is filled with..DI water until its surface touches the bottom of hydrogel plate. 
An 80mM MgCl2 solution of 0.8ml is carefully spread on the top surface of the hydrogel plate. 
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An Orion StarTM A212 Conductivity Benchtop Meter with an Orion™ DuraProbe™ 4-Electrode 
Conductivity Cell (Thermo Fisher Scientific, Waltham, MA, USA) is used to measure the 
conductivity of the water beneath the hydrogel plate. This measurement indicates the quantity of 
salt ions that have diffused through the hydrogel plate into the water beneath. A stir bar rotates at 
300rpm during the measurement. The beaker is covered with plastic wrap to prevent the 
evaporation.  
 
To show the permeability of plasmin through the hydrogel plate, an enzyme-linked 
immunosorbent assay (ELISA) is performed. Human PLG / Plasmin / Plasminogen ELISA Kit 
(Sandwich ELISA) (LifeSpan BioSciences, Inc.) is used in this study according to the 
manufacturer’s instructions. A standard curve (Figure 5-3) is generated to convert optical density 
at 450nm measured by an EnSpire Multimode Plate Reader (PerkinElmer) to plasmin 
concentration. Hydrogel plates of 4mm in thickness are supported in a petri dish (60mm in 
diameter, 15mm in height, polystyrene, Falcon, Corning). DI water (22ml) is poured into the 
petri dish so that the water surface touches the bottom of the hydrogel plate. The 0.33U/ml 
plasmin solution (1ml) is loaded on top of the hydrogel. After 2.5 hours, ~300µl of the liquid 
beneath the bottom surface of the hydrogel plate is sampled. This liquid is tested with ELISA 
and the final concentration is determined from the standard curve (Figure 5-3). 
 
 
128 
	
Figure 5-3 | Standard curve of plasmin concentration measured by ELISA 
The relationship between the transmittance and the plasmin concentration (with 3.3×108 
excluded) is regressed: Plasmin	conc. = 1×108H ∗ 𝑡𝑟𝑎𝑛𝑠𝑚𝑖𝑡𝑡𝑎𝑛𝑐𝑒.H, the dotted line 
indicates. Transmittance readings of four replicates in the experiment of plasmin diffusing 
through hydrogel were 0.182, 0.052, 0.089 and 0.079.   
 
5.3.7 Rheometry 
Three different types of rheometers (AR-G2, TA Instruments; Discovery HR-2, TA Instruments; 
MCR 702 rheometer, Anton Paar) are used to test the performance of hydrogel plates generated 
by the two methods. The tests include small amplitude oscillatory shear as a function of 
frequency and creep tests in the linear regime.  For kinetic tests, small amplitude oscillatory 
shear was performed at a frequency 𝜔 =	0.1 Hz with a strain amplitude in the linear regime.  
Experiments were performed in a humid environment.  As necessary, sample desiccation was 
prevented by coating sample edges with a thin layer of mineral oil. 
 
 
10-8 10-7 10-6 10-5 10-4 10-3
0.001
0.01
0.1
1
10
plasmin conc. [U/ml]
Tr
an
sm
itt
an
ce
 a
t 4
50
nm
 
129 
5.3.8 Hydrogel Cone Generation 
To create a hydrogel cone, a bottom mold complementary to the cone shape is designed in 
OpenSCAD (Marius Kintel, Clifford Wolf) and generated by three-dimensional (3D) printing 
(3D Systems, Viper Stereo-Lithography): 54mm in diameter, 2° in cone angle, 60𝜇𝑚 in truncate 
gap.  Accura 60 – a transparent, polycarbonate-like plastic – is used as the 3D printing material 
because of its favorable UV transmittance. To generate the hydrogel cone fixture, the 3D-printed 
bottom mold replaces the flat petri dish or glass slide in the procedure described earlier. For 
evaluation, we take photos and detect the edge of the cone in Python 3.6.4 as shown in Figure 
7(b). The beveled side of the cone is fitted with a line by linear regression and the R-square value 
is calculated. The conical surface is also detected and fitted with a line. The angle of the cone is 
then calculated to be the angle of between the two lines. 
 
5.4 Results: 
5.4.1 Hydrogel Plate Performance 
In Figure 5-4a, we compare the small amplitude oscillatory shear of a 4.0 wt% PEO solution, as 
characterized using the hydrogel plate geometry, as generated by visual alignment (c.f. Methods), 
and a commercial stainless steel plate.  The measurement gap is 500 𝜇𝑚 the strain amplitude of 
0.30 is within the linear regime of this material.  The values of G′ and G// measured with the 
hydrogel plate agree well with that measured with the stainless steel tooling.  Averaging over the 
whole curve, the mean relative error between the two fixtures is 17% for G’ and 10% for G’’. 
 
In Figure 5-4b, the measured creep response is reported.  It is characteristic of a viscoelastic 
liquid.  The agreement between the results for the two hydrogen and stainless steel plates is very 
good.  At the start of the creep test, oscillations in the compliance, also known as inertio-elastic 
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“ringing,” are observed. This response results from the coupling of instrument inertia and sample 
elasticity 17. The instrument inertia calibration before every experiment for both the hydrogel 
plate and the stainless steel plate is done following the manufacturer protocol, which measures 
the acceleration at a constant torque 18. The overlap of the curves measured by the hydrogel plate 
and the commercial plate shows that the effect of the hydrogel plate instrument inertia is the 
same as from the stainless steel fixture. It also shows the precision of the hydrogel plate in 
measuring transient rheological response.  
	
Figure 5-4 | Rheometric tests comparing a stainless steel plate (60mm in diameter) and a 
hydrogel plate (53mm in diameter), as produced by the visual alignment method 
 (a) Linear viscoelastic response of a 4.0 wt.% PEO solution at γ = 0.3. (b) Transient creep tests 
of 0.75 wt.% gellan gum solution at fixed stress 𝜏6= 10Pa and gap = 500𝜇𝑚. 
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We compare the rheometry measurements of a 4wt.% PEO solution using a commercial glass 
plate (Anton Paar) and a hydrogel plate centered by mechanical alignment. Both the small-
amplitude oscillatory shear rheology results (Figure 5-5a) and the transient creep test results 
(Figure 5-5b) show excellent agreement between the performance of the hydrogel plate and the 
glass plate.  In this case the mean relative error is 8.6% for G’ and 7.9% for G”. 
 
	
Figure 5-5 | Rheometric tests of a 4 wt.% PEO solution comparing a glass plate (43mm in 
diameter from Anton Paar) and a mechanically aligned hydrogel plate (43mm in diameter)  
 (a) Frequency sweeps at fixed γ = 0.3. (b) Transient creep tests, at fixed stress 𝜏6= 10Pa, gap = 
500𝜇𝑚.  
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5.4.2 Applications 
Here we report two example applications of the porous hydrogel tooling for rheological 
measurements. In the first application, we deliver salt ions through the hydrogel plate to a 
colloidal suspension while measuring its change in 𝐺′ during the colloidal gelation.  
 
We first show the permeability of MgCl2 through the hydrogel plate by loading the MgCl2 
solution on top of the hydrogel plate and measuring the conductivity change over time in the 
water beneath the hydrogel. The transport of salt ions through the hydrogel plate is driven by the 
concentration gradient since the salt concentration on top of the hydrogel plate is high and the 
concentration in the water beneath the hydrogel plate is initially zero. As shown in Figure 5-6a 
and 5b, initially there is no significant change in the conductivity of the water beneath the 
hydrogel.  After about two hours, there is a sudden increase. The conductivity continues to 
increase, until it slows down and approaches a plateau. The two-hour lag time before significant 
increase in conductivity is consistent with diffusion through the hydrogel.  Specifically, an ion of 
diffusivity 3.3×108	𝑚𝑚@/𝑚𝑖𝑛   requires 120 min to traverse the 4 mm thickness of the 
hydrogel.   
 
In Figure 5-6, we show how the diffusion of salt ions triggers a colloidal gelation process as 
characterized by measurement of the elastic modulus, 𝐺′. Without salt ions, 𝐺′ of the colloidal 
suspension is essentially noise, with an average value of 0.04 ± 0.03𝑃𝑎. When the salt ions 
diffuse into the colloidal suspension with a profile shown in Figure 5b, the 𝐺′ value of the 
colloidal suspension remains as noise with an average value of 0.08 ± 0.04𝑃𝑎  for 101 ±17	𝑚𝑖𝑛  before the start of the gelation, which we define as time zero. The 𝐺′  value then 
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increases from around 0.08 ± 0.04𝑃𝑎 to 1.5 ± 0.8𝑃𝑎 6000 seconds after time zero. This result 
indicates the successful delivery of salt ions through the hydrogel rheometry tooling.  
 
	
Figure 5-6 | Colloidal gelation triggered by salt diffusion through porous hydrogel 
rheometer plate 
(a) The change of conductivity over time in the water beneath the hydrogel plate with 0.8ml 
80mM MgCl2 solution loaded on top of the hydrogel fixture. The conductivity is normalized 
with the maximum conductivity when all the loaded salt solution is mixed in the water. (b) Detail 
of change of conductivity in the first four hours. (c) The time-dependent linear elastic modulus, 𝐺', at fixed strain = 0.003, for 1𝜇𝑚 colloidal polystyrene suspension loaded beneath the hydrogel 
plate and 0.8ml 80mM MgCl2 (blue points) or 0.8ml DI water (black points) loaded on top. 
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Time zero is defined as the start of the colloidal gelation and is taken as the point in which the 
change in 𝐺' value (moving average of five points) is continuously increasing. Error bars indicate 
standard error of the mean of three replicates; the increase in modulus indicates gelation.  
In the other application, we deliver a fibrinolytic enzyme – plasmin – through the hydrogel to a 
fibrin network and measure the linear elastic modulus during fibrin network degradation. Under 
the conditions of this experiment, plasmin concentration in the sample under the hydrogel plate 
after 2.5 hours is determined to be 1.4 ± 0.9 ×108H U/ml. As showed in Figure 5-7, without 
plasmin, the 𝐺′ value initially increases rapidly when the fibrinogen in the plasma solution 
polymerizes into a fibrin network triggered by the calcium chloride.  𝐺′ then reaches a plateau of 66 ± 4𝑃𝑎. When plasmin is loaded on top of the hydrogel plate, the 𝐺′ value also initially 
increases due to fibrin network formation; after around two hours, the 𝐺′ value starts to decrease 
and reaches a lower plateau (𝐺/~16 ± 10𝑃𝑎) at around three hours.  The decrease in elastic 
modulus confirms the delivery of plasmin through the hydrogel fixture. 
 
	
Figure 5-7 | The linear elastic modulus of a fibrin network degraded by plasmin via 
diffusion through the hydrogel membrane 
0 5000 10000 15000
0.1
1
10
100
t [s]
G
' [
Pa
]
plasmin 
water control
 
135 
The change of the elastic modulus, 𝐺′, over time with platelet-poor-plasma loaded beneath the 
hydrogel plate (initiated at time 0 with calcium chloride) and 1ml 0.33U/ml plasmin solution or 
1ml DI water loaded on top. Error bars indicate standard deviation of three replicates.  
 
5.4.3 Hydrogel Cone and Plate Fixture 
Figure 5-8 shows the hydrogel cone produced using a 3D printed mold (c.f. Methods). The edge 
of the cone is detected by image analysis in Figure 7(b). We fit the the edges to lines by linear 
regression (𝑅@ = 0.9 ± 0.04, n=3) and calculate the cone angle (2.5 ± 0.5, n=3) (c.f. Methods). 
Figure 7(c) shows its performance for rheological characterization is also shown.  The 𝐺′ and 𝐺′′ 
values measured by the hydrogel cone match well with those measured with a stainless steel 
cone. The frequency range of characterization is three decades.  
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Figure 5-8 | Hydrogel cone and plate geometry 
 (a) An image of a hydrogel cone generated with the 3D-printed bottom mold. The red lines 
indicate the cone angle. Scale bar = 10 cm. The cone angle is measured to be 2°. (b) The edge of 
the cone plate detected by image analysis in Python. (c) A comparison of frequency sweeps of a 
4.0 wt.% PEO solution measured with a steel cone and a hydrogel cone, produced using the 
visual alignment method. 
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5.5  Discussion: 
In this study, we report the development of hydrogel geometries for rheometry that allow the 
delivery of additives across the rheometer fixture and into the sample during measurements. We 
first showed that the performance of the hydrogel plate geometry is as good as both glass and 
stainless steel plates in oscillatory viscoelasticity and transient rheology (creep) measurements. 
We then offered two examples of applications in which salt ions were delivered to a colloidal 
suspension so as to gel it and plasmin was delivered to a fibrin network so as to degrade it.  The 
kinetic response of the rheology to these changes could be directly monitored because of the in 
situ delivery. We finally report that the same approach can be used to produce a permeable 
hydrogel cone and plate geometry, with the assistance of 3D printing. Overall, the hydrogel 
rheometer tooling opens up a wide range of possibilities for in situ delivery of additives during 
rheometry measurements in both scientific and industrial settings. Here we consider limitations 
of the method as well as potential future work that might promote additional applications of it.  
 
One limitation of the hydrogel fixture is that it is sensitive to changes in ambient humidity, 
because of its high water content.  Upon desiccation, the fixture becomes brittle, and it becomes 
more prone to cracking. Therefore, when working with the hydrogel tooling, it is important to 
control its aqueous content by soaking the hydrogel in water, using a humidifier, or applying a 
solvent trap.  Fortunately, solvent traps and other devices to control humidity are increasingly 
standard features of rheometers.  To illustrate the effects of desiccation, we repeated the 
conductivity measurement shown in Figure 5-6a and 5b with a hydrogel plate of the same 
thickness and diameter that had cracked due to desiccation. The result is shown in Figure 5-9. 
The conductivity begins to increase rapidly about 20 minutes after the salt solution is loaded on 
top of the hydrogel plate as opposed to two hours with a crack free hydrogel plate.  
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Figure 5-9 | The transient conductivity profile over time for a hydrogel plate with visible 
cracking, presented as comparison to the intact fixture of Figure 5-6 
 (a) Visible cracking of the hydrogel, scale bar = 10 cm; (b) zoomed-in image of the cracks, scale 
bar = 2 cm; (c) the change of conductivity over time a 400 ml reservoir beneath the hydrogel 
plate with 0.8ml 80mM MgCl2 solution loaded on top of the cracked hydrogel plate shown in (a). 
The conductivity is normalized by the maximum conductivity. (b) The change of conductivity in 
the first two hours; to be compared to Figure 5-6a and 5-6b. The lag time before an obvious 
increases in conductivity is significantly shorter than a non-cracked hydrogel plate in Figure 5-
6a,b. 
 
A consequence of inadvertent fixture desiccation is thus that the delivery of the additive through 
the hydrogel will be compromised (or uncontrolled) due to heterogonous channels inside the 
 
139 
plate. Although sometimes the consequences of desiccation are cracks that are clearly visible, we 
should also concern ourselves with the possibility that the cracks might be microscopic.  
Dessication-induced cracking at the interface between the hydrogel of the fixture and the 
stainless steel spindle that is used to attach the fixture to the rheometer drive shaft is of particular 
concern. 
 
Although the ambient humidity was carefully controlled and no cracks were observed in all the 
fixtures used here, we performed some auxiliary experiments to check for fixture micro-cracking. 
First, we soaked a hydrogel fixture for three hours in a food coloring solution and did not 
observe any micro-cracking due to enhanced coloration of the dye.  Second, we observed a 5.3×5.3	𝑚𝑚@  section of a hydrogel plate fixture under 10X magnification, and also did not 
observe any micro-cracks.  These additional results are shown in Figure 5-10.  
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Figure 5-10 | Microcrack visualization 
 (a) Hydrogel plate (43mm in diameter) fixture produced under the experimental conditions in 
which humidity is properly controlled for three hours and (c) soaked in a food coloring solution 
for another three hours; no visible cracks or channels are detected; (b) fixture with artificially 
produced cracks by a blade and (d) dyed with food coloring to show that cracks become easier to 
see when dyed. A 5.3×5.3	𝑚𝑚@ section of a hydrogel plate fixture (e) with no visible cracks 
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detected and (f) with artificially cracked produced by a blade dyed with food coloring under 10X 
magnification.  A Scale bar = 1mm. 
 
Another limitation of the porous hydrogel tooling is the potential for vertical heterogeneity in the 
sample as a consequence of the time that it takes for the additive to diffuse through the sample 
itself.  That is, since the additive diffuses through the hydrogel to the top surface of the sample, it 
may trigger change in the specimen at different times in planes perpendicular to the direction of 
diffusion. Thus, the real-time variation in mechanical properties measured this way is the change 
in the sample surface rather than an ensemble average of the whole sample.  As an estimate of 
the significance of this effect, consider the time for a small species (e.g., Na+ and Cl- ions) to 
diffuse through the typical gap dimensions (e.g., 500 microns) of a parallel plate rheometry 
experiment. The characteristic time for diffusion across this distance is about 30 seconds for an 
aqueous solution.  Therefore, kinetic effects on a specimen will be a convolution of the 
properties of the different axial slices for time scales less than this duration.  
 
A potential limitation of the permeability of the hydrogel tooling is the existence of an osmotic 
pressure gradient across the hydrogel fixture, particular for delivery of salt solutions. A gradient 
of osmotic pressure may drive mass flux that would cause a change in the measured normal force 
over time. In Figure 5-11, we show that a 4 wt.% PEO solution has a gradual change in normal 
force during a steady shear test measured by hydrogel plate with salt solution loaded on top, as 
compared to that measured by a stainless steel plate and a hydrogel plate with water loaded on 
top. It suggests that there could be some effect of the osmotic pressure gradient across the 
membrane, which may influence the measured normal force.  
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Figure 5-11 | Effect of osmotic pressure during the diffusion of salt ions. 
Normal Stress over time during a steady shear test (shear rate = 0.1 s-1) of a 4 wt.% PEO 
solution measured with a stainless steel plate (20mm in diameter), hydrogel plate (53mm in 
diameter) with 1ml water and 1ml 80mM MgCl2 solution on top of the plate.   
 
Because of its finite thickness, there is a lag between when the additive solution is first applied 
on top of the fixture, and when it first affects conditions of the specimen.  We offer the following 
procedures to control this lag in delivery of the additive: 1) A simple way to speed up the 
delivery rate is to pre-soak the hydrogel plate in the additive solution to be delivered. In Figure 
5-12, we pre-soak the hydrogel plate in an 80mM MgCl2 solution overnight and repeat the 
experiment of Figure 5-6a and 5-6b.  The pre-soaking leads to a faster initial delivery rate; 2) 
One could also control the thickness of the hydrogel plate to reduce initial lag times. In this study, 
the minimum thickness of the hydrogel plate is 4 mm. This thickness was needed so that the 
plate fully covered the spindle, which in the present case is a stainless steel cone with small 
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diameter.  3) Another way to address diffusion times across the hydrogel membrane would be to 
control the hydrogel pore size through variation of the concentration and the molecular weight of 
the PEGDA to vary the pore size of the hydrogel 19. The concentration and type of the 
photoinitiator as well as the UV exposure time all play a role in controlling the pore size.  4) One 
could also vary the material to control the fixture permeability. To be selected as a porous 
rheometry tooling, a material would need to be rigid and permeable to an extent that allows the 
desired additive to traverse the fixture.  
 
	
Figure 5-12 | The transient conductivity profile over time for hydrogel plate pre-soaked in 
the additive solution (80mM MgCl2) overnight 
 (a) The change of conductivity over time in the water beneath the hydrogel plate when 0.8ml 
80mM MgCl2 solution is then top-loaded. (c.f. Methods). The conductivity is normalized by the 
maximum conductivity. (b) The change of conductivity in the first two hours can be compared to 
Figure 5-6a and 5-6b in the main text. As opposed to the ~2 hours lag time before an obvious 
increases in conductivity in Figure 5-6a,b, the conductivity increases immediately at time zero 
when the hydrogel plate touches the DI water beneath. 
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6 Chapter 6: Conclusions and Future Work 
 
The overall goal of this dissertation is to determine the impact of bacteria on the mechanics, 
structure and instability of a fibrin network in two limits of a spectrum of possibilities:  In one 
limit, the role of bacterial cell growth is minimized by direct introduction of the physiologically 
relevant concentration of bacterial cells and then study of the effect of these cells on fibrin 
network formation. In the second limit, the role of fibrin network formation kinetics is 
minimized by pre-assembly of a fibrin network in which bacterial cells are then introduced and 
allowed to proliferate. The molecular mechanisms are also explored to aid in the understanding 
of the characterized phenomena.  
 
In Chapter 2, we built an in vitro new model for medical device infection – that of a fibrin 
network infected with the common blood borne pathogen Staphylococcus epidermidis. We find 
that S.epidermidis influences a fibrin network mechanically and structurally on both 
microscopic and macroscopic scales. S.epidermidis present during clot formation produces a 
visibly disorganized microstructure that increases clot stiffness and triggers mechanical 
instability over time.  
 
This work provides insight into clot heterogeneity shows that S. epidermidis can rupture a fibrin 
clot.  The resultant embolization of the infected clot can contribute to the systemic dissemination 
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of the pathogen. This work has drawn attention on the role of host proteins on medical device 
infection in addition to bacterial biofilms. It inspired the research in the rest of my dissertation.   
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In Chapter 3, we explained a potential molecular mechanism that leads to the phenomena noticed 
in Chapter 2. We noticed that stationary-phase (biofilm-like) S. epidermidis has a more robust 
effect on fibrin formation kinetics, mechanics and structure than exponential-phase (planktonic) 
ones. We continued to find that stationary-phase S. epidermidis has an increased adhesion to 
fibrinogen. Furthermore, the gene expression for SdrG – the protein that adheres S. epidermidis 
cells to fibrinogen was significantly increased in the stationary phase. We therefore implied that 
bacterial interaction with fibrinogen could be a factor that determines bacterial effect on fibrin.  
 
This work shows how the bacterial interaction with fibrin on a molecular scale could impact the 
formation, mechanics and structure of a host fibrin network. It also contributes to the current 
understanding of the growth phase dependent regulation of bacterial virulent factors and the 
correlation between bacterial infection and thrombosis. 
 
In Chapter 4, the role of fibrin network formation kinetics is minimized by pre-assembly of a 
fibrin network in which bacterial cells are then introduced and allowed to proliferate into a 
biofilm. Under this scenario, we extended our study on infected fibrin by investigating a specific 
protein – IcaB, a cell surface-attached protein that has a key role in staphylococcal biofilm 
formation and immune evasion. It deacetylates and introduces positive charge to polysaccharide 
intercellular adhesin (PIA) molecules; these charges facilitate adhesion of bacterial cells within a 
biofilm cluster. We find that an icaB deletion mutant (∆𝑖𝑐𝑎𝐵) degrades fibrin networks to a 
higher degree than the wild-type, both structurally and mechanically. Indeed, the ∆𝑖𝑐𝑎𝐵 
produced more sspA, a protease that putatively degrades fibrin. We further demonstrate that the 
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∆𝑖𝑐𝑎𝐵 cells, which are more mobile and diffusive than the wild type cells, co-localize with the 
fibrin fibers. This co-localization is correlated with fibrin network degradation.  
 
This work suggests a pivotal role for icaB in modulating staphylococcal bacterial-fibrin 
interactions and resulting fibrin mechanical structure. This dynamic could be relevant to a 
potential molecular mechanism for infection-induced thromboembolism.  
 
In our study of infected fibrin, we noticed some limitations in the mechanics characterization 
using rheometers, e.g. the challenge of delivering additives in situ. This inspired us to develop a 
rheometer tooling comprised of a porous hydrogel in Chapter 5. The tooling allows additives to 
be dosed through a rheometer plate or cone, and the consequent effect of these additives on a 
material’s mechanical response measured. We demonstrated that the tooling can be used to study 
the kinetics of material property variation due to the diffusion of molecular additives into the soft 
material though the hydrogel plate.  
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Figure 6-1 | Mechanistic sketches 
Mechanistic sketches of (a) fibrin formation; (b) fibrin formation at the presence of exponential-
phase bacterial cells; (c) fibrin formation at the presence of stationary-phase bacterial cells; (d) 
pre-assembled fibrin network with proliferating S.epi 1457 wild-type bacteria biofilms; (e) pre-
assembled fibrin network with proliferating S.epi 1457 ∆icaB bacteria biofilms 
 
Figure 6-11 summarizes the mechanism we propose that may lead to the observed phenomena in 
this dissertation. Once we mix thrombin into fibrinogen solution, thrombin cleaves fibrinogen 
and triggers the polymerization of fibrin. The presence of stationary-phase bacterial cells in this 
process introduces cell-protein attraction and adhesion which can arise from both specific and 
non-specific interactions as explained in the previous chapters. As described in chapter 2, the 
reduced fibrin formation kinetics can arise from the adhesion of thrombin to cell surfaces, which 
leads to a drop of thrombin concentration. Alternatively, fibrinogen adherence on cell surfaces 
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may also contribute to the delayed fibrin formation and the two step clotting process as shown in 
Figure 2-7: the first clotting step could be the polymerization of the less concentrated free-
floating fibrinogen and the second clotting process happens presumably when the fibrin oligomer 
coated bacterial cells join the network. This may also explain that the bacterial cells, starting 
from free floating, adhere onto fibrin fibers over time.  
 
The formation of a heterogeneous fibrin network can arise from the heterogeneous distribution of 
fibrinogen caused by cell-fibrinogen attraction. Alternatively, the large pore size population may 
be formed with the free-floating less concentrated fibrinogen and the small pore size population 
may be formed with the localized fibrin oligomers adhered on cell surfaces. The presence of 
exponential-phase bacterial cells does not generate a significant impact on fibrin structure nor 
mechanics. This indicates that there could be a threshold below which cell-protein attraction and 
adhesion may not always influence fibrin formation.  
 
In the long term, we observed enlarged voids and increase structural heterogeneity in fibrin 
formed at the presence of stationary-phase bacterial cells. Mechanically, bacterial cells may 
apply a force on the fibrin network due to gravity. Chemically, bacteria may produce SspA that 
putatively degrade fibrin. This phenomenon does not apply to exponential-phase bacteria either 
because 1) not as many bacteria are adhered on fibrin fibers and 2) they do not produce SspA as 
much as stationary-phase cells as shown in Figure 3-3. 
 
Figure 6-1 (d, e) explained the proposed mechanisms of the other scenario where bacteria are 
proliferating in a pre-assembled fibrin network. An S.epidermidis wild-type cell grows into a 
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biofilm cluster whose location depends on the initial bacterial cell location and is independent of 
fibrin fibers. The bacterial cells produce SspA that locally degrades fibrin around the cells. On 
the other hand, a ∆𝑖𝑐𝑎𝐵 cell,without de-acetylated PIA molecules attaching to its surface, divides 
into cells that are diffusive so that they have chances to bump into fibrin fibers. Once they bump 
into a fibrin fiber, they are likely to adhere to it due to its negative charges. Therefore, the ∆𝑖𝑐𝑎𝐵 
cells co-localize with the fibrin fibers. Moreover, they express a higher amount of SspA (Figure 
4-8). Both the co-localization and the increased expression of SspA contribute to the observed 
higher degree of fibrin degradation. 
 
One of the questions encouraged by the study of fibrin formation at the presence of bacteria is 
the theoretical mechanisms that lead to the two step clotting process and the formation of the 
heterogeneous fibrin structure. In Figure 6-1 we propose some hypothesis that may be tested by 
mathematical simulations together with experimental characterizations of the involved forces. 
Another question this study inspires is the general relationship between fibrin structural and 
fibrin mechanical properties. In chapter 2, we propose a mathematical model that associate the 
heterogeneous fibrin structure to the different fibrin stiffness. Alternative explanations may also 
stand. For example, the additional mass of bacteria and the change in fibrin fiber bundles by the 
cells may both have a contribution to the change in the mechanical properties of an infected 
fibrin network. 
 
In the future, we would also like to expand the study of infected fibrin to a more physiological 
conditions. An example would be an infected whole blood clot in a flow. An experimental model 
we would like to propose is to have a whole blood clot, infected or not, attached to a microfluidic 
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device that allows flows and the collection and size measurement of potential emboli. With this 
model, we may study how embolic events could be influenced by the presence of bacteria, flow 
rate, types of flow, etc. Potential limitations of this model may include the control of blood clot 
sizes and the attachment of clots to device wall. 
 
Overall, this dissertation has contributed to the understanding of medical device infections and 
infection-induced thromboembolism. It opens up discussion of the interaction mechanisms 
between bacteria and embolism with potential implications for treating septic thromboembolism. 
The infected clot model could also be used to study other situations – such as chronic wound 
healing and scar formation – in which bacteria and clot co-present in the human body.  
 
